Introduction {#s1}
============

Multicellular animals owe their complexity to their capacity to produce and maintain different lineages composed of multiple cell types that share virtually the same genomic DNA. Such complexity requires a tight regulation of gene expression to unambiguously specify and constrain the developmental path taken by cells within and between different lineages. Cell fates are controlled by networks of transcription factors (TFs) that act in the context of the genomic chromatin state to activate transcriptional programs realizing the distinct properties of cells of a given lineage ([@bib36]; [@bib54]; [@bib97]). The forced expression of TFs expressed only in one lineage like Myoblast Determination Protein (MyoD), which is sufficient to alter cell identity ([@bib103]; [@bib109]), showed that lineage-restricted TFs can act as major lineage switches by activating lineage-specific transcriptional programs. However, recent profiling experiments revealed that global gene expression and chromatin accessibility changes are imperfect even in MyoD reprogrammed cells, showing that these highly potent reprogramming TFs cannot completely erase the original cell or lineage fate and unequivocally induce the new one ([@bib62]). In addition, lineage choice does not only involve the activation of one lineage-specific transcriptional program but also the repression of the programs of all alternative lineages ([@bib50]; [@bib60]), a regulatory wiring that needs to be faithfully accomplished in all the different lineages. Although lineage-restricted TFs could in principle fulfil this function, it would ask for a highly complex regulatory architecture. On the other hand, TFs expressed in multiple/all lineages with a rather promiscuous binding behaviour would dramatically reduce this complexity and would elegantly explain lineage-specific gene regulation based on the interaction of these broadly expressed TFs with lineage-restricted factors.

Hox TFs represent an excellent model to address this fundamental question, since they are active in all lineages along the anterior-posterior (AP) axis of bilaterian animals. Importantly, the famous and well-known identity switch of whole body parts, the homeotic transformation, which is induced by altered Hox expression ([@bib55]; [@bib93]), shows that Hox TFs have comparable functions in all lineages during development and indicates that they control the development of different lineages in a highly specific manner. The latter conclusion is supported by recent experiments showing that mesoderm-derived vascular wall mesenchymal stem cells (VW-MSCs) can be generated in vitro from induced pluripotent stem cells (iPSCs) simply by inducing the expression of a mixture of *Hox* genes that are selectively expressed in adult VM-MSCs ([@bib98]). However, while this study showed that *Hox* genes alone are sufficient to induce the generation of one specific cell type of one lineage in vitro, it left the questions open whether this is also the case in vivo, and how Hox TFs unambiguously select among the many possible transcriptional programs only one, which drives a cell or a whole lineage into one specific direction.

One major bottleneck in this direction is that genome-wide Hox chromatin binding studies have been performed so far mainly in cell culture systems ([@bib8]; [@bib116]), specialized epithelial tissues ([@bib1]), or mixtures of cell lineages ([@bib95]), hampering the identification of common and lineage-specific mechanisms employed by Hox TFs in different lineages in vivo. Furthermore, unlike lineage-restricted TFs, which are often tested in vivo using ectopic expression systems ([@bib31]; [@bib76]), the functional analysis of TFs acting in multiple lineages requires the targeted interference with these factors in individual lineages. With the availability of conditional genome editing ([@bib82]; [@bib81]) and nanobody driven protein degradation systems ([@bib16]) this is now possible in an efficient manner and allows to elucidate the mode of action of Hox TFs in individual lineages, which are located in an otherwise unperturbed tissue environment at any stage in development. This is particularly important for multi-lineage TFs like the Hox proteins, which extensively control cell communication ([@bib19]; [@bib77]) and thus influence their own action in neighbouring lineages.

Here, we probe the Hox TF Ubx in the mesodermal and neuronal lineages using sorted nuclei of *Drosophila* embryos and by interfering with Ubx function specifically in the mesoderm lineage that is specified and fully committed to the mesodermal fate. To this end, we generated a GFP-Ubx gene fusion at the endogenous locus using CRISPR-Cas9 and homologous recombination. We show that Ubx is a key regulator of lineage development and diversification, as it controls the mesodermal and neuronal transcriptional programs with high specificity despite interacting with many genes in both lineages. Intriguingly, our study demonstrates that Ubx controls lineage specification and differentiation not primarily by activating lineage-specific gene programs but to a large extent by restricting cellular plasticity within each lineage. In the mesoderm Ubx executes this function by silencing alternative fate genes, and we show that this repression requires the interaction of Ubx with the Polycomb Group (PcG) protein Pleiohomeotic (Pho) on co-bound chromatin sites. We furthermore find that Ubx stabilizes Pho binding to Ubx targeted genomic regions, and that this interaction is critical for gene repression by controlling the balance of H3K27me3 as well as H3K27ac at these sites. Taken together, our study demonstrates that Hox TFs control not only the segmental identity but also the developmental programs intrinsic to each lineage with high precision, and that one of the prominent functions of this multi-lineage TF family is the repression of alternative lineage programs, which restricts the cellular potential in a lineage-specific manner.

Results {#s2}
=======

A comprehensive map of transcriptional profiles and Ubx binding in the *Drosophila* embryonic mesodermal and neuronal lineages {#s2-1}
------------------------------------------------------------------------------------------------------------------------------

To elucidate mechanisms that enable a multi-lineage TF to instruct the development of divergent lineages, we recorded on the tissue level chromatin binding of the broadly expressed Hox protein Ubx in the mesoderm and nervous system and determined the transcriptomes of these two lineages during two stages of *Drosophila* embryogenesis. To this end, we used the [i]{.ul}solation of [n]{.ul}uclei [ta]{.ul}gged in specific [c]{.ul}ell [t]{.ul}ypes (INTACT) method ([@bib99]) by inducing the expression of the nuclear membrane protein Ran GTPase activating protein (RanGAP) fused to a biotin ligase acceptor peptide and the *E. coli* Biotin ligase (BirA) in the mesoderm via the pan-mesodermal *twist* (*twi*) ([@bib52]) or the pan-neuronal *embryonic lethal abnormal vision* (*elav*)([@bib87]; [@bib110]) regulatory regions. Co-expression of both transgenes in *Drosophila* embryos, which did not affect development ([Figure 1---figure supplement 1C--1H](#fig1s1){ref-type="fig"}), resulted in cell type-specific biotinylation of nuclei in vivo ([Figure 1A--C'](#fig1){ref-type="fig"}). Mesodermal or neuronal nuclei were efficiently isolated using Streptavidin-coated beads, as we detected Mef2-positive nuclei and concomitantly mesodermal marker gene expression like *Mef2 and nautilus* (*nau*) almost exclusively in the mesodermal collection ([Figure 1D](#fig1){ref-type="fig"}), while Elav-labelled neuronal nuclei and neuronal marker genes like *eagle* (*eg*) and *elav* were found highly enriched in the neuronal fraction only ([Figure 1---figure supplement 1A--B](#fig1s1){ref-type="fig"}).

![Comparative profiling of the mesodermal and neuronal transcriptomes in *Drosophila* embryos.\
(**A, A'**) Lateral views of stage 11 (**A**) and stage 14 (**A'**) *twi-INTACT Drosophila* embryos stained for the muscle differentiation marker Mef2 (green) and Streptavidin (red). (**B, B'**) Lateral view of stage 11 (**B**) and stage 14 (**B'**) *elav \>INTACT Drosophila* embryos stained for the pan-neuronal marker Elav (green) and Streptavidin (red). (**C, C'**) Nuclei obtained from *twi-INTACT* embryos stained for Mef2 (red), Elav (green) and DAPI (blue) before (**C**) and after (**C'**) INTACT purification. (**D**) Expression of mesodermal (*Mef2*, *nau*) and ectodermal (*en*) mRNA transcripts in nuclei purified from *twi*-INTACT embryos as measured by RT-PCR using RNA from total/input (10%), purified and unbound nuclei. (**E**) Principle Component Analysis (PCA) applied to all RNA-seq samples identifies three clusters: one corresponding to mesodermal specification events (mesoderm^10-13^), one to mesodermal differentiation events (mesoderm^14-17^) and the neuronal cluster sharing similar expression signatures. The two mesodermal cluster are distinct from the neuronal and result in the mesodermal group. (**F**) Pearson correlation analysis highlights the differences and similarities between the mesodermal and neuronal RNA-seq datasets. (**G, H**) Left: MA analysis identifies genes differentially expressed in the mesodermal and neuronal lineages at two different time windows, embryonic stage 10--13 (**G**) and embryonic stage 14--17 (**H**). Genes differentially expressed in the mesodermal lineage are indicated as green dots, those in the neuronal lineage as purple dots. Right: Bar diagram displaying fold enrichment of gene ontology terms of genes differentially expressed in the mesodermal or neuronal lineages at the two different time windows.](elife-42675-fig1){#fig1}

We analysed the nuclear transcriptome by high-throughput RNA sequencing (RNA-seq) using INTACT-sorted mesodermal or neuronal nuclei obtained from stage 10 to 13 (4--9 hr after egg lay (AEL)) and stage 14 to 17 embryos (10--18 hr AEL). Robust and reproducible data were obtained for all samples in biological duplicates. In total, transcripts (containing \>5 RPKM) corresponding to 5652 coding genes were identified for the early mesodermal, 5716 coding genes for late mesodermal, 6752 coding genes for the early neuronal and 6182 coding genes for the late neuronal nuclei populations, which included genes typical for the lineage type and developmental stage ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). Pearson correlation coefficient analysis revealed that the transcriptome of the mesodermal lineage was clearly distinct from the neuronal one at both time points (r = 0.72 for stages^10-13^; r = 0.53 for stages^14-17^) ([Figure 1F](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1I](#fig1s1){ref-type="fig"}). This was also reflected in a high number of genes differentially expressed in the mesodermal as well as the neuronal lineages when comparing identical stages ([Figure 1G,H](#fig1){ref-type="fig"}). Importantly, GO term classification revealed a significant enrichment of processes typical for the respective lineage (mesoderm both stages: p-value\<2.2e-16, neuronal stages^10-13^: p-value\<1.26e-6, neuronal stages^14-17^: p-value\<5.3e-5) ([Figure 1G and H](#fig1){ref-type="fig"}). In addition to elucidating differences in tissue profiles, Pearson correlation coefficient analysis also showed that global gene expression in the mesodermal lineage changed substantially over the selected time points (r = 0.78 for mesoderm stages^10-13^ + stages^14-17^) ([Figure 1F and H](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1I](#fig1s1){ref-type="fig"}). Tissue- and stage-dependent differences and similarities were very well reflected in the distances calculated by principal component analysis (PCA) ([Figure 1E](#fig1){ref-type="fig"}). PCA analysis also showed that in contrast to the mesoderm the neuronal transcriptomes were very similar at both developmental time frames ([Figure 1---figure supplement 1I](#fig1s1){ref-type="fig"}), which we assumed to be a consequence of the earlier onset of nervous system differentiation ([@bib7]; [@bib33]).

We next profiled genome-wide Ubx binding in the same lineages and identical time windows by chromatin immunoprecipitation coupled to massively parallel sequencing (ChIP-seq) using 1 × 10^6^ INTACT-sorted mesodermal and neuronal nuclei and an Ubx specific antibody generated and verified in the lab (see Materials and Methods). The sequencing was performed in biological duplicates and Pearson correlation coefficient analysis revealed a high similarity of the samples (r = 0.94--0.96). The data were benchmarked by the identification of Ubx binding to known target loci, including the well-characterized interaction of Ubx with the *decapentaplegic* (*dpp*) ([@bib15]; [@bib61]) ([Figure 2A](#fig2){ref-type="fig"}) and *β-Tubulin at 60D* (*βTub60D*) ([@bib48]) ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}) enhancers. We found Ubx to interact with both enhancers using chromatin from INTACT sorted mesodermal but not neuronal nuclei ([Figure 2A](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}), showing that our data reflected Ubx interactions in vivo. However, this analysis also uncovered that Ubx, which is known to have different functions in the developing mesoderm and nervous system ([@bib24]; [@bib35]; [@bib64]; [@bib66]) and which interacted with different genomic regions in the two tissue lineages ([Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}), targeted many genes in both tissue lineages ([Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}). To resolve this discrepancy, we overlapped Ubx binding events and transcriptome profiles. We found that only 27% to 36% of the Ubx chromatin interactions occurred in the vicinity of genes actively transcribed either in the mesodermal or neuronal lineages at the different stages ([Figure 2B](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}), with more than 60% of these interactions occurring at intron, intergenic and distal enhancer regions ([Figure 2E](#fig2){ref-type="fig"}). This included *Mef2*, *teashirt* (*tsh*) and *βTub60D* in early and *tin* (*tin*), *α-Actinin* (*Actn*) and *Tropomyosin 1* (*Tm1*) in late mesodermal nuclei, while in early neuronal nuclei *deadpan* (*dpn*), *huckebein* (*hkb*) and *Neurotrophin 1* (*NT1*) in late neuronal nuclei *Neuroglian* (*Nrg*), *target of PoxN* (*tap*) and *castor* (*cas*) was among the Ubx bound active genes. In contrast, a large portion of the Ubx chromatin interactions (64% to 73%) were close to inactive genes in the two lineages ([Figure 2B](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}) While it is well documented that Hox TFs function as activators and repressors depending on the context ([@bib80]; [@bib89]), the high number of Ubx chromatin interactions at non-transcribed genes was unexpected. By determining the gene functions associated with Ubx interactions, we found a substantial overrepresentation of GO terms characteristic for the respective lineage among the Ubx targeted and expressed genes (mesoderm: p-value 2.2e-16, neuronal stages^10-13^: p-value 2.2e-16, neuronal stages^14-17^: p-value 1.004e-9) ([Figure 2C,D](#fig2){ref-type="fig"}), while Ubx interactions at inactive genes occurred frequently at genes controlling processes active in other lineages ([Figure 2---figure supplements 1B](#fig2s1){ref-type="fig"}--[2D](#fig2s2){ref-type="fig"}). For example, ectodermal and neuronal but not mesodermal GO terms (p-value 0.7118) were highly enriched among the inactive genes bound by Ubx in the early mesodermal lineage (neuronal GO-terms: p-value 0.0008442, ectoderm GO terms: p-value 0.01196).

![Ubx comprehensively controls tissue-specific transcriptional programs.\
(**A**) ChIP-seq binding profiles of Ubx at the *dpp* genomic locus in mesodermal (green) and neuronal (purple) nuclei. The different isoforms of the *dpp* gene are shown in blue, the known *dpp* visceral enhancer in red. The box highlights Ubx binding to the *dpp* visceral enhancer in mesodermal but not in neuronal cells. (**B**) Venn diagrams representing the overlaps between the mesodermal (green) and neuronal (purple) transcriptomes and Ubx bound genes (orange) at two different stages. (**C, D**) Fold enrichment of gene ontology terms of genes expressed and targeted by Ubx in the mesoderm (**C**) or the neuronal (**D**) tissues, respectively. (**E**) Comparison of the localisation of peaks called within unique genomic regions of Ubx. Locations are classified as promoters (−1000- + 10 bp from TSS, 5' UTR), distal enhancers (−2000 to −1000 from TSS, 3' UTR, downstream), intron (intronic regions), intergenic (distal intergenic) and other regions (including exons). (**F**) Venn diagrams representing the overlaps between the mesodermal (green) transcriptomes and Tin bound genes (red) at two different stages. (**G**) Heat-map displaying presence of genes belonging to higher-order categories in the different gene classes. The colour range corresponds to the centred and scaled (per column) fraction of genes annotated to the category that also appear in the sample: red colour represents high values, blue colours low fractions of genes in the category, which are also present in the sample. Rows and columns are hierarchically clustered using Euclidean distance with complete linkage. The blue and green boxes highlight the distributions of functional terms among the expressed and Ubx targeted as well as the inactive and Ubx targeted genes.](elife-42675-fig2){#fig2}

In order to comprehensively analyse the binding behaviour of Ubx to active and inactive genes, we used the WEADE tool, which identifies and visualizes overrepresentation of functionally related biological GO terms assembled to higher-order GO term sets and allows the representation and comparative analysis of multiple gene sets ([@bib107]). This analysis uncovered a high correlation between the lineage-specific transcriptional profiles and the genome-wide Ubx interactions ([Figure 2G](#fig2){ref-type="fig"}). For example, many genes expressed in the early mesoderm control stem cell, cell cycle and translation related processes, and Ubx interactions were found enriched in the vicinity of these genes, while Ubx hardly interacted with genes encoding gene functions that were not represented among the active genes, like metabolism, signalling, stimulus and transport/trafficking related functions ([Figure 2G](#fig2){ref-type="fig"}). A similar correlation was found among the inactive genes, as Ubx interactions were again highly enriched at gene classes found to be overrepresented among the non-expressed genes, while Ubx did not interact with underrepresented gene classes ([Figure 2G](#fig2){ref-type="fig"}). This result suggested that Ubx binding controlled global gene expression in the mesoderm, the activation as well as repression, in a comprehensive manner. However, as this GO term enrichment could also be a consequence of the high number of genes bound by Ubx and not of binding preferences, we performed two types of analyses. First, we mapped the Ubx sequencing reads retrieved from stage 10 to 13 mesodermal nuclei to a previous version of the *Drosophila* genome (dm3). This resulted as expected in the identification of substantially fewer binding events ([Figure 2---figure supplement 2B](#fig2s2){ref-type="fig"}), however the genes targeted by Ubx had still a similar distribution of GO term enrichments when compared to the transcriptome according to WEADE analysis ([Figure 2---figure supplement 2C](#fig2s2){ref-type="fig"}). And second, we asked whether this binding behaviour was a general characteristic of TFs or specific for Ubx. Thus, we analysed GO term enrichment of genes bound by two mesoderm-specific TFs, Tinman (Tin), a NK homeodomain TF required for cardiac development ([@bib11]) ([@bib4]), and Myocyte enhancer factor 2 (Mef2), a MADS-box TF generally controlling muscle development ([@bib13]) ([@bib86]). We used genome-wide binding data of Tin and Mef2 profiled at similar embryonic stages which were mapped to the dm3 *Drosophila* genome ([@bib39]; [@bib90]), and which showed that Ubx, Tin and Mef2 bound comparable numbers of chromatin sites ([Figure 2---figure supplement 2B](#fig2s2){ref-type="fig"}). WEADE analysis of genes bound by these two TFs revealed that Tin interactions did not reflect very well the gene classes represented among the active and inactive genes, while Ubx and Mef2 profiles were rather similar ([Figure 2G](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2B,C](#fig2s2){ref-type="fig"}). Indeed, Tin preferentially interacted with genes controlling stem cell processes irrespective of whether these genes were actively transcribed or silent ([Figure 2G](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2C](#fig2s2){ref-type="fig"}). Thus, these results strengthened our hypothesis that Ubx generally controls mesoderm development like Mef2, while Tin has a more restricted function in this tissue lineage. This is in line with Tin's published role in the determination and specification of the cardiac, visceral and dorsal mesoderm ([@bib4]; [@bib45]).

In sum, these results illustrated that the broadly expressed Hox TF Ubx played a prominent role in orchestrating the transcriptional program in the mesodermal (and neuronal) lineages. In addition, our analysis revealed that a substantial fraction of Ubx interactions were found in the vicinity of inactive genes, which encoded many mesoderm-unrelated functions. Thus, we hypothesized that one important function of Ubx in tissue development could be the repression of alternative transcriptional programs, which instruct the development of other lineages.

The generic Hox transcription factor Ubx functions as a major regulator of lineage programs {#s2-2}
-------------------------------------------------------------------------------------------

Our analysis of Ubx function in the mesodermal and neuronal lineages was so far based on correlating lineage-specific Ubx binding profiles with RNA-seq probed gene expression. In order to elucidate which genes are under direct Ubx control, we profiled the transcriptional output induced in mesodermal cells devoid of Ubx protein, while leaving Ubx levels in all other cell and tissue types unchanged. We focused our analysis on the mesoderm, as its control by various lineage-restricted TFs is well described ([@bib4]; [@bib45]; [@bib58]; [@bib90]; [@bib91]; [@bib113]). In order to deplete Ubx in the mesoderm, we used the targeted degradation of GFP fusion proteins. To this end, we first generated an endogenously GFP tagged version of the *Ubx* gene using the [C]{.ul}lustered [R]{.ul}egularly [I]{.ul}nterspaced [S]{.ul}hort [P]{.ul}alindromic [R]{.ul}epeats-associated Cas9 (CRISPR/Cas9)-mediated genome engineering ([Figure 3---figure supplement 1A,B](#fig3s1){ref-type="fig"}) ([@bib6]; [@bib32]) (see Materials and Methods for details). Intactness of the fusion protein in the homozygous viable GFP-Ubx fly line was verified by rescuing *Ubx* mutants using the *GFP-Ubx* allele ([Figure 3---figure supplement 1H--L](#fig3s1){ref-type="fig"}). Co-localization of GFP and Ubx protein expression in GFP-Ubx embryos ([Figure 3A,B](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1C,D](#fig3s1){ref-type="fig"}) confirmed a precise expression control of the fusion protein. In order to degrade the GFP-Ubx fusion protein in a lineage-specific manner, we used the deGradFP system, which harnesses the ubiquitin-proteasome pathway to achieve direct depletion of GFP-tagged proteins. We first functionally verified the system by ubiquitously degrading the GFP-Ubx fusion protein using the *armadillo* (*arm*)-GAL4 driver, which resulted in a strong reduction of GFP-Ubx protein levels ([Figure 3---figure supplement 1E--G,O](#fig3s1){ref-type="fig"}), and in animals resembling the *Ubx* null mutant phenotype ([Figure 3---figure supplement 1M,N](#fig3s1){ref-type="fig"}) ([@bib55]). In a next step, we applied deGradFP to specifically interfere with Ubx function in the mesoderm using the *Mef2*-GAL4 driver ([@bib114]). This combination substantially decreased GFP-Ubx protein accumulation in the mesoderm ([Figure 3C,D,G](#fig3){ref-type="fig"}), and the expression of the direct Ubx target gene *dpp* in the visceral mesoderm ([Figure 3H--J](#fig3){ref-type="fig"}) ([@bib61]; [@bib112]). Consequently, we only observed the well-described loss of the third midgut constriction in these embryos ([Figure 3E,F](#fig3){ref-type="fig"}), which is caused by the absence of Ubx activity in this tissue ([@bib9]), while all non-mesodermal tissues were unaffected ([Figure 3E--G](#fig3){ref-type="fig"}). Having confirmed the suitability of the approach, we INTACT-sorted mesodermal nuclei, in which the GFP-Ubx protein had been depleted and profiled their transcriptome using RNA-seq. Due to the activity of the *Mef2*-GAL4 driver starting at embryonic stage 7 ([@bib114]), which resulted in significant reduction of Ubx protein levels in the mesoderm only at stage 12 ([Figure 3C,D](#fig3){ref-type="fig"}), we restricted our analysis to the late developmental time window (embryonic stages 14 to 17). RNA-seq experiments where performed in biological triplicates and the two most similar duplicates identified by Person correlation were used for further analysis. Comparison of the Ubx depleted and control mesodermal transcriptomes revealed a differential expression of 2845 genes, with 1393 genes showing increased mRNA accumulation, including *Fasciclin 2* (*Fas2*), *ventral veins lacking* (*vvl*), *Neurotrophin 1* (*NT1*) and *myospheroid* (*mys*), while 1452 genes exhibited reduced expression, including *βTub60D*, *Ankyrin 2* (*Ank2*) and *Notchless* (*Nle*) ([Figure 3K](#fig3){ref-type="fig"}). PCA analysis confirmed that the mesodermal transcriptomes in the absence (mesoderm^14-17^ Ubx^Degrad^) or presence (mesoderm^14-17^) of Ubx were substantially different ([Figure 3N](#fig3){ref-type="fig"}). In total, 55% (791/1452) of the genes with reduced and 70% (978/1393) of the genes with increased expression were bound by Ubx in mesodermal nuclei in wild-type embryos, implying that the majority of expression changes were a direct consequence of altered Ubx chromatin interactions. A detailed analysis of biological GO terms showed that down-regulated genes mostly functioned in general cell processes like translation, RNA processing and gene expression ([Figure 3L](#fig3){ref-type="fig"}), while up-regulated genes controlled primarily lineage-specific functions like central nervous system, axon and cutical development ([Figure 3L](#fig3){ref-type="fig"}). To have a global view of the biological processes directly controlled by Ubx, we compared overrepresentation of higher-order biological GO terms between the Ubx degradation and control transcriptomes sets using the WEADE tool. We observed that processes were not randomly changed in the absence of Ubx but were mostly in agreement with Ubx chromatin binding ([Figure 3M](#fig3){ref-type="fig"}). For example, translation and cell cycle processes, which were enriched among the expressed as well as Ubx bound active genes in the control transcriptome, were now represented among the transcripts with reduced accumulation in the absence of Ubx ([Figure 3M](#fig3){ref-type="fig"}), supporting that these processes were directly activated by Ubx. On the other hand, stimulus and signalling related processes, which were only to a minor extent represented among the genes expressed in the mesoderm, were found enriched among the genes with enhanced activity in the absence of Ubx ([Figure 3M](#fig3){ref-type="fig"}). Consistent with a repressive function of Ubx, these processes were overrepresented among the inactive genes bound by Ubx in control mesodermal nuclei ([Figure 3M](#fig3){ref-type="fig"}).

![Ubx directly represses alternative fate genes in a lineage-specific manner.\
(**A, B**) Lateral view of stage 14 *GFP-Ubx Drosophila* embryos stained for the muscle differentiation marker Mef2 (blue) (**A**), the pan-neuronal marker Elav (blue) (**B**), Ubx (red) and GFP (green). Boxes indicate the location of the close-ups on the right panel. (**C--F**) Lateral view of stage 15 *Mef2-GAL4,GFP-Ubx* and *Mef2 \>Nslmb,GFP-Ubx Drosophila* embryos stained for Tm1 (blue) to indicate the differentiated muscles and GFP (green) to highlight GFP-Ubx expression. The boxes in (**C, D**) mark GFP expression in muscle cells of the 2^nd^ abdominal segment (**A2**), which is lost when Ubx is degraded, while the ectodermal expression in the 1^st^ abdominal segment (**A1**) is unaffected (marked by orange arrowheads). In (**E, F**), GFP expression in the CNS and the visceral mesoderm (marked by yellow arrowheads) is shown. GFP expression in the visceral mesoderm is lost in *Mef2 \>Nslmb,GFP-Ubx Drosophila* embryos (**F**), leading to a loss of the second midgut constriction. (**G**) Quantification of GFP signal intensity in the mesoderm and the CNS of *Mef2-GAL4,GFP-Ubx* and *Mef2 \>Nslmb,GFP-Ubx Drosophila* embryos, showing that GFP is strongly decreased in the mesoderm (\*\*=p \< 0.01). (**H, I**) *lacZ* mRNA expression in stage 14 *UAS-Nslmb,dpp-lacZ,GFP-Ubx* and *Mef2 \>Nslmb,dpp-lacZ,GFP-Ubx Drosophila* embryos, highlighting that mesoderm-specific depletion of Ubx leads to a loss of *dpp-lacZ* enhancer activity (indicated by yellow arrowheads), a known and direct target of Ubx control ([@bib15]; [@bib61]). The orange arrowheads highlight unspecific enhancer activity in the salivary glands. (**J**) Quantification of *lacZ* signal intensity in *UAS-Nslmb,dpp-lacZ,GFP-Ubx* and *Mef2 \>Nslmb,dpp-lacZ,GFP-Ubx* embryos, showing that *lacZ* expression is strongly decreased (\*\*=p \< 0.01). (**K**) Volcano plot displaying the differentially expressed genes between *UAS-Nslmb,GFP-Ubx* and *Mef2 \>Nslmb,GFP-Ubx* INTACT-sorted mesodermal nuclei. The y-axis corresponds to the mean expression value of log10 (p-value), and the x-axis displays the log2 fold change value. The orange dots represent transcripts whose expression is down-regulated (padj-value \<0.1), the blue dots represent the up-regulated expressed transcripts (padj-value \<0.1) between *UAS-Nslmb,GFP-Ubx* and *Mef2 \>Nslmb,GFP-Ubx* INTACT-sorted mesodermal nuclei. (**L**) Fold enrichment of gene ontology terms of down- (orange) and up-regulated (blue) genes in *Mef2 \>Nslmb,GFP-Ubx* vs. *UAS-Nslmb,GFP-Ubx* mesodermal nuclei. (**M**) Heat-map displaying presence of genes belonging to higher-order categories in the different gene classes. The colour range corresponds to the centred and scaled (per column) fraction of genes annotated to the category that also appear in the sample: red colour represents high values, blue colours low fractions of genes in the category, which are also present in the sample. Rows and columns are hierarchically clustered using Euclidean distance with complete linkage. (**N**) PCA applied to all RNA-seq samples identifies the separation of the Ubx^deGrad^ dataset from the two mesodermal as well as the neuronal datasets. (**O**) Multiple testing of higher-order GO-terms related to different lineages among different gene classes. The y-axis corresponds to the p-value, the x-axis displays the different categories of tested genes. Neuronal and ectodermal as well as gut/endoderm related GO-terms are significantly enriched in the tested samples.](elife-42675-fig3){#fig3}

Intriguingly, we found differentiation processes to be enriched among the genes up-regulated in the absence of Ubx ([Figure 3L,M](#fig3){ref-type="fig"}). Analysing differentiation processes revealed that processes controlling the development of lineages other than the mesoderm, including the neuronal, ectodermal end endodermal lineages, were predominantly represented among the up-regulated genes in Ubx depleted mesodermal cells ([Figure 3L](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1P](#fig3s1){ref-type="fig"}), which was significantly higher than expected by chance (neuronal and ectoderm: p-value\<2.2e-16, endoderm and gut structures: p-value 5.04e-14). Comparing these genes to the neuronal transcriptomes, which we have generated, showed that 56% (774/1393) of the up-regulated genes were normally expressed and functional in the neuronal lineage in the wild type situation ([Figure 3---figure supplement 1P](#fig3s1){ref-type="fig"}), while the remaining 44% (617/1393) were active in other lineages according to GO term prediction (data not shown).

Taken together, these results showed that Ubx controlled a large number of genes encoding diverse functions. The strong correlation between Ubx binding with specifically repressed or activated classes of genes suggested that Ubx indeed exerts a dominant influence over the mesodermal transcriptome at the two stages analysed. In addition, this analysis highlighted that Ubx repressed many genes controlling the establishment of non-mesodermal, alternative lineages, indicating that Ubx could have a pivotal role in restricting the developmental potential of cells and tissues, thereby ensuring that lineages adopt a unique identity.

Ubx represses alternative fate genes by organizing the epigenetic landscape {#s2-3}
---------------------------------------------------------------------------

One intriguing of this study finding was the high number of genes repressed by Ubx, which encoded primarily functions related to other lineages ([Figure 3L](#fig3){ref-type="fig"}). As this suggested that Ubx carves the developmental path of a cell or tissue lineage by inhibiting other possible developmental routes, we focused our subsequent analysis on the question how Ubx executes this lineage-restricting function. As gene expression critically depends on the epigenetic status of the gene regulatory control regions ([@bib44]; [@bib56]), we characterized Ubx chromatin interactions in more detail. To this end, we mapped two key modifications of the nucleosome component Histone H3, H3K27me3, a mark associated with repressive chromatin ([@bib26]; [@bib42]), as well as H3K27ac, a mark associated with active promoters and enhancers ([@bib12]; [@bib85]), by ChIPseq using INTACT-sorted mesodermal nuclei. The ChIP-seq for histone marks was performed in biological duplicates. This analysis revealed that in the early mesoderm about 30% of all Ubx chromatin interactions overlapped with H3K27me3 peaks and about 20% with H3K27ac peaks, while in the late mesoderm 40% of all Ubx chromatin interactions overlapped with H3K27me3 peaks and 73% with H3K27ac peaks ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). Ubx interactions with repressive chromatin were predictive of gene activity, as about 70% of these occurred at inactive genes irrespective of the developmental stage ([Figure 4B](#fig4){ref-type="fig"}), which we found again associated with functions unrelated to the mesoderm (neuronal: p-value 7.05e-5--6.59e-6, ectoderm: p-value 4.80e-5--5.21e-7) ([Figure 4C](#fig4){ref-type="fig"}). In contrast, less than half of the Ubx interactions with active chromatin occurred close to active genes ([Figure 4B](#fig4){ref-type="fig"}), which were as before enriched for mesoderm-related functions ([Figure 4C](#fig4){ref-type="fig"}), while the rest were found close to inactive genes ([Figure 4B](#fig4){ref-type="fig"}). Organizing chromatin environment by genomic location revealed that only a minor fraction (about 20%) of the Ubx bound repressive chromatin regions occurred at promoters, while the majority was found at putative distal enhancers, in introns and intergenic regions in both developmental time points ([Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"}).

![Ubx represses alternative fate genes by organizing the epigenetic landscape.\
(**A**) ChIP-seq binding profiles of Ubx (green), H3K27ac (light +dark orange) and H3K27me3 (light +dark red) in control (*UAS-Nslmb,GFP-Ubx*) (light orange +red) and Ubx^DeGrad^ (*Mef2 \>Nslmb,GFP-Ubx*) (dark orange +red) mesodermal nuclei at the *vnd* genomic locus (blue), a gene up-regulated in the absence of Ubx. (**B**) Venn diagrams representing the overlaps between genes expressed in the mesoderm (green), which are targeted by Ubx and simultaneously associated with H3K27ac (Ubx +H3K27ac, purple) or H3K27me3 (Ubx +H3K27me3, red) marks, respectively. (**C**) Fold enrichment of gene ontology terms among the genes expressed, targeted by Ubx and associated with H3K27ac marks (Ubx +K27ac^14-17^ active, blue) and the genes not expressed in the mesoderm, targeted by Ubx and associated with H3K27me3 marks (Ubx +K27me3^14-17^ inactive, red). (**D**) Left panel: Venn diagram representing the overlap between genes up-regulated in Ubx depleted mesodermal nuclei (beige) and genes associated with histone mark changes indicative for gene activation (gain/increase in H3K27 acetylation, loss/reduction in H3K27 tri-methylation) (brown). Right panel: Fold enrichment of gene ontology terms of the 164 genes, which have histone changes to activation and are up-regulated in Ubx depleted mesodermal nuclei. (**E**) Volcano plot displaying the changes of H3K27ac and H3K27me3 marks between *UAS-Nslmb,GFP-Ubx* (control) and *Mef2 \>Nslmb,GFP-Ubx* (degrade) INTACT-sorted mesodermal nuclei using differential binding analysis of ChIP-Seq peaks (DiffBind). The y-axis corresponds to the mean expression value of log10 (p-value), and the x-axis displays the difference of the log2 fold change value in Ubx^Degrad^ compared to the log2 of the control. The orange dots represent genomic regions containing an increase in H3K27ac or H3K27me3 (p-value\<0.05), the red dots represent genomic regions containing a decrease in H3K27ac or H3K27me3 (p-value\<0.05) between *UAS-Nslmb,GFP-Ubx* and *Mef2 \>Nslmb,GFP-Ubx* INTACT-sorted mesodermal nuclei. (**F**) Comparison of H3K27ac or H3K27me3 fold enrichments at Ubx targeted genomic regions that experienced histone changes towards activation represented as Violin plots. Quantification of the histone changes in Ubx bound upregulated (164) and unchanged genes (894) by using the results of the differential binding analysis of ChIP-Seq peaks. The y-axis displays the fold change calculated by DiffBind. The x-axis shows all selected regions (upregulated and unchanged) and a sub-division of the regions in promoter (−1000 to +10 from TSS, 5' UTR) and enhancer (distal enhancers (−2000 to −1000 from TSS), 3' UTR, downstream, intronic regions, distal intergenic). Each sample contains a significant increase in H3K27ac levels (yellow), H3K27me3 levels (red) are decreased, but enhancer regions close to genes not changed in their expression have significantly higher H3K27me3 levels than enhancers close to genes up-regulated after Ubx depletion (\*=p \< 0.05).](elife-42675-fig4){#fig4}

In a next step, we asked how the epigenetic landscape changed in the absence of Ubx, in particular at genomic regions with overlapping Ubx and repressive H3K27me3 marks. To this end, we performed ChIP-seq experiments in biological triplicates, the two most similar duplicates were used for further analysis. In total, 1216 H3K27me3 peaks and 1480 H3K27ac peaks located in gene regulatory regions, which corresponded to 2768 genes, changed their chromatin state in the absence of Ubx, as they experienced either a reduction/loss or an increase/gain in tri-methylation/acetylation at lysine 27 of histone 3 ([Figure 4E](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1E](#fig4s1){ref-type="fig"}). Importantly, 80% of these genomic regions possessed an Ubx binding peak in control mesodermal cells, indicating that Ubx was critically required for establishing or maintaining the majority of these histone marks. Intriguingly, 1058 of these genes were primed for gene expression, as they experienced a loss/reduction of H3K27me3 and/or gain/increase of H3K27ac in their regulatory regions ([Figure 4D](#fig4){ref-type="fig"}), and 164 of them were indeed up-regulated in the mesodermal lineage in the absence of Ubx ([Figure 4D](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}). Consistent with previous results, these 164 genes were highly enriched for processes critically controlling the development of lineages other than the mesoderm (neuronal: p-value\<2.2e-16, ectoderm: p-value 1.36e-12, endoderm and gut structures: p-value\<2.2e-16) ([Figure 4D](#fig4){ref-type="fig"}).

One result that puzzled us was that the majority of genes primed for activation (894 of 1058) remained silent on the RNA level when Ubx was lineage-specifically degraded ([Figure 4D](#fig4){ref-type="fig"}). In order to resolve this discrepancy, we analysed H3K27me3 and H3K27ac changes at introns, intergenic and distal enhancer regions, which we collectively labelled enhancers ([Figure 4F](#fig4){ref-type="fig"}), as well as at promoters. We found that H3K27ac marks were equally increased at promoters and enhancers of genes unchanged or up-regulated in the absence of Ubx ([Figure 4F](#fig4){ref-type="fig"}). However, while H3K27me3 marks were significantly decreased at enhancers as well as promoters of up-regulated genes, unchanged genes showed a significant increase in H3K27me3 at their enhancers ([Figure 4F](#fig4){ref-type="fig"}). As a high proportion of Ubx and H3K27me3 peaks co-occurred at enhancers ([Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"}), this result revealed that Ubx played a major role in repressing the expression of alternative fate genes by controlling the deposition/maintenance of H3K27me3 marks at enhancers.

In sum, these results showed that Ubx mediated the repression of genes encoding non-mesodermal functions by controlling the epigenetic status, in particular H3K27me3, at Ubx bound chromatin sites located in enhancers.

Ubx interacts with Pho at H3K27me3 marked inactive genes encoding alternative fate genes {#s2-4}
----------------------------------------------------------------------------------------

To identify factors that together with Ubx could mediate the repression of alternative fate genes thereby restricting lineage identity, we performed a DNA motif search using all Ubx peaks either overlapping with H3K27me3 repressive or H3K27ac active marks. We found in both cases motifs for Ubx, Extradenticle (Exd), a TALE class homeobox TF functioning as Hox cofactor in invertebrates and vertebrates ([@bib63]; [@bib67]), and Trithorax-like (Trl), a GAGA factor activating and repressing gene expression by chromatin modification ([@bib44]), among the highest ranking motifs. In contrast, the DNA binding motif for the zinc finger protein Pleiohomeotic (Pho) was specifically enriched only among the co-occurring Ubx and H3K27me3 binding events ([Figure 5A](#fig5){ref-type="fig"}). Interestingly, it has been shown just recently that in the absence of Pho, which recruits PcGs to PREs ([@bib27]; [@bib30]; [@bib40]), H3K27me3 marks were reduced in Polycomb regions and redistributed to heterochromatin ([@bib14]). In combination with our finding that H3K27me3 levels were reduced specifically at up-regulated genes ([Figure 4F](#fig4){ref-type="fig"}), we hypothesized that Pho could function together with Ubx in the lineage-specific repression of alternative fate genes. Consistent with this idea Pho was found expressed in mesodermal cells also expressing Ubx ([Figure 5B-C''](#fig5){ref-type="fig"}). Furthermore, we confirmed a weak interaction of Ubx and Pho proteins in a complex in vitro and in vivo by performing co-immunoprecipitation (Co-IP) experiments *in cellulo* using *Drosophila* S2R + cells transfected with tagged versions of Ubx and Pho as well as in vivo using GFP-Ubx embryos ([Figure 5F,G](#fig5){ref-type="fig"}). This result suggested that Ubx and Pho could interact with the same chromatin regions to control gene expression, thus we analysed high-resolution Pho maps retrieved from embryonic (stage 9 to 12) mesodermal cells ([@bib25]). We found 4814 chromatin regions (which represent 62% of the Ubx and 12% of the Pho binding events) to be co-bound by Ubx and Pho and marked by H3K27me3 in stage 14--17 mesodermal cells ([Figures 5D](#fig5){ref-type="fig"} and [6A](#fig6){ref-type="fig"}), with 40% of these events occurring at promoters and 49% at enhancers (data not shown). Consistent with the reported role of Pho in transcriptional repression ([@bib27]; [@bib30]; [@bib40]), 66% (3099/4715) of the genes bound by Ubx and Pho as well as marked by H3K27me3 were not expressed in the mesoderm ([Figure 5D](#fig5){ref-type="fig"}), and GO term analysis revealed that the majority of the genes encoded non-mesodermal and stem cell-related functions (neuronal: p-value 1,62e-4, ectodermal: 1,71e-5) ([Figure 5E](#fig5){ref-type="fig"}). This was different for the remaining 1616 genes also bound by Ubx and Pho and marked by H3K27me3 but expressed in mesodermal cells, as they encoded gene functions controlling processes typical for the tissue type and developmental stage ([Figure 5E](#fig5){ref-type="fig"}). By analysing the distribution of H3K27me3 and H3K27ac at regulatory regions, we discovered that those chromatin regions associated with inactive genes had a higher coverage of H3K27me3 and lower coverage of H3K27ac at shared Ubx/Pho binding regions, while it was the opposite for active genes ([Figure 5I](#fig5){ref-type="fig"}). Furthermore, the canonical Pho binding motif was found overrepresented only among the Ubx/Pho/H3K27me3 chromatin regions associated with genes inactive in the mesoderm ([Figure 5H](#fig5){ref-type="fig"}), while other DNA binding motifs, including the ones for Ubx, Exd and Trl, were overrepresented in Ubx/Pho/H3K27me3 chromatin regions associated with inactive as well as active genes.

![Ubx interacts with Pho at H3K27me3 marked inactive genes encoding alternative fate genes.\
(**A**) The top four hits from MEME-ChIP analysis using all Ubx targeted, H3K27ac marked genomic regions in the vicinity of expressed genes (Ubx +H3K27ac) or Ubx targeted, H3K27me3 marked genomic regions in the vicinity of inactive genes (Ubx +H3K27me3) as input. While the Ubx, Exd and Trl motifs were found over-represented in both datasets, the Pho motif was found over-represented only in the Ubx +H3K27me3 dataset. (**B--B''**) Lateral view of stage 11 wild-type *Drosophila* embryos stained for the mesodermal marker Org-1 (blue), Ubx (red) and Pho (green). (**B'**) and (**B''**) are dual colour images of (**B**), highlighting that Ubx and Pho are co-expressed in Org-1 labelled mesodermal cells. (**C--C''**) Lateral view of stage 11 *Mef2 \>nlsGFP Drosophila* embryos stained for GFP (blue), Ubx (red) and Pho (green). (**C'**) and (**C''**) are dual colour images of (**C**). (**D**) Left: Venn diagram representing the overlap between Ubx targeted and H3K27me3 marked chromatin regions (orange) and Pho binding peaks (pink) in stage 14--17 mesodermal nuclei. Right: Venn diagram representing the overlap between genes targeted by Ubx +Pho and marked by H3K27me3 (purple) and the genes expressed in the mesoderm (green). (**E**) Fold enrichment of gene ontology terms of the genes targeted by Ubx and Pho, which are additionally marked by H3K27me3 and either not expressed (3578) or expressed (1137) in mesodermal cells. (**F**) Co-immunoprecipitation of exogenous GFP fusion proteins using GFP-trap beads after transfection of S2R + *Drosophila* cells with HA-Pho coupled with GFP-nls (negative control), GFP-Ubx WT or N51A (mutant of the homeodomain, Asparagine 51 replaced by Alanine residue). Western blots were probed with the indicated antibodies. Pho is detected in the immunoprecipitated fraction of GFP-Ubx WT and N51A, while it is absent in the GFP negative control. (**G**) Co-immunoprecipitation with the GFP-trap system of endogenous proteins performed on nuclear extract from embryos expressing (or not) the endogenous GFP-Ubx fusion protein. Pho co-immunoprecipitates with GFP-Ubx, while it is absent from w1118 fly line. (**H**) MEME-ChIP analysis using Ubx and Pho targeted chromatin regions marked by H3K27me3 located in the vicinity of active or inactive genes identifies the classical Pho motif over-represented only in the vicinity of inactive genes. (**I**) Quantification of H3K27ac and H3K27me3 distributions at Ubx and Pho targeted chromatin regions marked by H3K27me3 located either in the vicinity of active or inactive genes are represented as Violin plot. The y-axis displays the coverage of the histone mark distribution in percent, the x-axis indicates the histone mark that was analysed. Active genes display a higher coverage of H3K27ac, while inactive genes have a higher coverage of H3K27me3 (\*\*\*=p \< 0.001).](elife-42675-fig5){#fig5}

![Ubx is required for stabilizing Pho binding to H3K27me3 chromatin regions.\
(**A**) ChIP-seq binding profiles of Ubx (green), Pho (Pho), H3K27ac (orange) and H3K27me3 (red) in mesodermal nuclei as well as RNA-seq profiles in *Mef2-GAL4,GFP-Ubx* control (yellow) versus and *Mef2 \>Nslmb,GFP-Ubx* (blue) mesodermal nuclei at the *Ptx1* genomic locus. The *Ptx1* gene are shown in blue. The box highlights the overlapping binding peaks of Ubx and Pho in the vicinity of the *Ptx1* coding region. (**B**) ChIP-qPCR experiments for Pho, H3K27ac and H3K27me3 using chromatin regions close to the *vnd*, *HGTX*, *Ptx1*, *ham* and *NT1* genes bound by Pho and Ubx using chromatin isolated from *UAS-Nslmb,GFP-Ubx* (light green) and *Mef2 \>Nslmb,GFP-Ubx* (dark green) mesodermal nuclei. As control locus sites, a exon region in the *scramb* genes was used, which is not bound by Pho nor by Ubx. All loci show a significant reduction of Pho binding, H3K27me3 levels were reduced at the HGTX associated Ubx/Pho chromatin regions. In the *vnd*, *Ptx1*, *ham* and NT1 associated Ubx/Pho loci H3K27ac levels are significantly enriched (\*=p \< 0.05, \*\*=p \< 0.01, \*\*\*=p \< 0.001). (**C--H**) Lateral view of stage 16 *Mef2-GAL4,GFP-Ubx* (**C, D**), *Mef2 \>Nslmb,GFP-Ubx* (**E, F**) and *phol^81A^;pho^1^* mutant (**G, H**) embryos stained for the muscle marker Tm1 (**C--H**) and for *vnd* (**C, E, G**) and *Ptx1* (**D, F, H**) transcripts. The yellow boxes highlight the lateral muscles. (**I, J**) Quantification of *vnd* (**I**) and *Ptx1* (**J**) signal intensities in the lateral muscles (as indicated by the yellow boxes) in *Mef2-GAL4,GFP-Ubx*, *Mef2 \>Nslmb,GFP-Ubx* and *phol^81A^;pho^1^* mutant embryos, showing that the expression of *vnd* and *Ptx1* is significantly increased in comparison to control embryos (\*=p \< 0.05).](elife-42675-fig6){#fig6}

These results demonstrated that Ubx interacted with Pho and that their interaction on H3K27me3 marked chromatin regions occurred preferentially at inactive genes in mesodermal cells.

Ubx is required for stabilizing pho binding to H3K27me3 chromatin regions {#s2-5}
-------------------------------------------------------------------------

Our results indicated that Ubx could mediate the repression of alternative fate genes by recruiting or stabilizing Pho binding at Ubx targeted genomic regions in the mesodermal lineage, thereby allowing the two proteins to act in a combinatorial fashion. In support of this hypothesis, we found 55% (769/1391) of the genes up-regulated in the absence of Ubx, which were highly enriched for non-mesodermal and stem cell related functions, to be located in the vicinity of Ubx/Pho binding regions ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). In contrast, only a minor fraction (15%) was in the vicinity of chromatin sites targeted by Pho only, and we did not detect any significant enrichment of GO terms among these genes (data not shown). To provide additional evidence for a combined action of Ubx and Pho, we analysed the binding of Pho to Ubx/Pho/H3K27me3 binding regions in the absence of Ubx by performing ChIP experiments on INTACT sorted control and Ubx depleted mesodermal nuclei. Furthermore, we also quantified the levels of H3K27me3 and H3K27ac marks at these loci. We selected five Ubx/Pho/H3K27me3 genomic regions that changed their histone marks towards activation (less H3K27me3 and/or more H3K27ac) when Ubx was depleted in the mesodermal lineage, which resulted in the activation of the associated genes encoding neuronal functions. This included *ventral nervous defective* (*vnd*), a NK2 class TF encoding gene critical for patterning of the neuroectoderm as well as the formation and specification of ventral neuroblasts ([@bib96]), *HGTX*, a homeodomain TF encoding gene promoting the specification and differentiation of motor neurons innervating the ventral body wall muscles ([@bib102]), *Neurotrophin 1* (*NT1*), a cytokine encoding a gene that regulates motor neuron survival and axon guidance, *hamlet* (*ham*), a gene encoding a PRDM class TF that regulates neuron fate selection in the peripheral nervous system ([@bib69]), and *Ptx1*, again a homeodomain TF encoding gene which is expressed at high levels in the early embryonic central nervous system and the midgut, and later also in ventral muscles ([@bib108]). In addition, we also chose five loci bound by Pho but not by Ubx, which were associated with genes normally not expressed in the mesoderm and which remained silent in the absence of Ubx, including *folded gastrulation* (*fog*), *Olig family* (*Oli*), *bendless* (*ben*), *myospheroid* (*mys*) and *medial glomeruli* (*meigo*). Strikingly, all five Ubx/Pho/H3K27me3 loci, which were co-bound by Ubx and Pho in the presence of Ubx ([Figure 6A](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}), experienced a dramatic loss of Pho binding when Ubx was degraded ([Figure 6B](#fig6){ref-type="fig"}). In contrast, Pho binding to Pho-only control loci remained unaffected ([Figure 6---figure supplement 1C](#fig6s1){ref-type="fig"}). As Pho expression levels were unaltered in the absence of Ubx ([Figure 7C](#fig7){ref-type="fig"}), we concluded that Ubx is required to stabilize Pho binding to chromatin of H3K27me3 marked loci. These results indicated that the expression of alternative fate genes should be similarly de-repressed in the mesoderm in the absence of either Ubx or Pho. In line with this hypothesis, we found the expression of *vnd* and *Ptx1*, which were normally not or only weakly expressed in mesodermal cells of stage 16 control embryos ([Figure 6C,D,I,J](#fig6){ref-type="fig"}) to be significantly increased in the mesoderm of *Mef2 \>Nslmb,GFP-Ubx* embryos ([Figure 6E,F,I,J](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1D,E](#fig6s1){ref-type="fig"}) as well as in *phol^81A^/pho^1^* double mutant embryos ([Figure 6G,H,I,J](#fig6){ref-type="fig"}). It has been recently reported that in the absence of Pho H3K27me3 enrichment was decreased ([@bib14]; [@bib47]), and consistently, we found that H3K27me3 levels at the *HGTX* and *ham* associated Ubx/Pho/H3K27me3 loci were significantly decreased in Ubx depleted mesodermal nuclei ([Figure 6B](#fig6){ref-type="fig"}). Importantly, while H3K27ac levels remained unaffected at the *HGTX* associated Ubx binding locus, they were increased at the *ham* associated Ubx/Pho/H3K27me3 region ([Figure 6B](#fig6){ref-type="fig"}). In contrast, H3K27me3 levels at Ubx/Pho/H3K27me3 loci associated with the *vnd*, *NT1* and *Ptx1* genes were not considerably decreased, however, these loci had significantly higher H3K27ac levels in the absence of Ubx ([Figure 6B](#fig6){ref-type="fig"}). These results revealed that in the absence of Ubx Pho's ability to interact with the five Ubx/Pho/H3K27me3 loci was strongly reduced and concomitantly H3K27me3 as well as H3K27ac levels were changed.

![General relevance of Pho dependency on Ubx.\
(**A**) MA plot displaying the changes of Pho binding between *UAS-Nslmb,GFP-Ubx* (control) and *Mef2 \>Nslmb;GFP-Ubx* (Ubx^deGrad^) INTACT-sorted mesodermal nuclei using differential binding analysis of ChIP-Seq peaks. The y-axis corresponds to the log fold change, and the x-axis displays the log concentration. (**B**) Left panel: Venn diagram representing an overlap between genomic regions co-bound by Ubx and Pho (Ubx/Pho, red) and regions that lose Pho binding in the Ubx^deGrad^ background. Right panel: Venn diagram illustrating the overlap between genomic regions co-bound by Ubx and Pho that experience a loss of Pho binding in the Ubx^deGrad^ (light blue) and regions containing a histone mark change towards activation in the Ubx depleted mesodermal nuclei (light red). (**C**) Expression of *pho* in in *UAS-Nslmb;GFP-Ubx* (control) and *Mef2 \>Nslmb;GFP-Ubx* (Ubx^deGrad^) mesodermal nuclei, fold change is normalized to Ribosomal protein L32 (RpL32). The expression of *pho* is not significantly changed in the mesodermal, INTACT- sorted nuclei (INTACT) upon Ubx depletion (Ubx^deGrad^) in comparison to the control sample. (**D**) Left panel: Venn diagram representing the overlap between genes up-regulated in Ubx depleted mesodermal nuclei (yellow) and genes associated with Ubx and Pho that experience a loss of Pho binding in the Ubx^deGrad^ (blue). Right panel: Fold enrichment of gene ontology terms of the 422 genes, which contain Ubx and Pho binding, lose Pho binding and are up-regulated in Ubx depleted mesodermal nuclei. (**F**) Comparison of H3K27ac or H3K27me3 fold enrichments at Ubx and Pho targeted genomic regions that experienced a loss of Pho binding, represented as Violin plots. Quantification of the different regions: 1) Ubx/Pho sites that lose Pho binding (2597), 2) Ubx/Pho sites that maintain Pho binding (7549), 3) Ubx/Pho sites that lose Pho binding and experiences a histone mark change (328). The y-axis displays the fold change calculated by DiffBind. The x-axis shows all selected regions as disrobed 1), 2) and 3). Regions that lose Pho binding and experiences a histone mark change (328) experience a significant increase in H3K27ac levels (yellow) and a decrease in H3K27me3 levels (red).](elife-42675-fig7){#fig7}

General relevance of Pho dependency on Ubx {#s2-6}
------------------------------------------

In a next step, we asked whether stabilization of Pho binding and maintenance of H3K27me3 and H3K27ac levels are generally dependent on Ubx. To this end, we performed ChIP-seq experiments in biological triplicates using a Pho antibody ([@bib46]) and INTACT-sorted mesodermal nuclei that were depleted for Ubx protein. In total, 4154 sites experienced a loss/reduction in Pho binding in the absence of Ubx ([Figure 7A](#fig7){ref-type="fig"}), while at 3324 sites Pho binding was gained or increased ([Figure 7A](#fig7){ref-type="fig"}). Intriguingly, 62% (2567/4154) of the regions, which lost Pho binding in the absence of Ubx, were co-bound by Ubx in control nuclei ([Figure 7B](#fig7){ref-type="fig"}), revealing a co-dependency of Ubx and Pho binding to shared chromatin sites. Notably, 422 of the 3501 genes associated with Ubx/Pho regions that lost Pho binding were up-regulated in Ubx depleted mesodermal nuclei ([Figure 7D](#fig7){ref-type="fig"}), which again encoded preferentially proteins controlling alternative fates ([Figure 7D](#fig7){ref-type="fig"}). Our analysis of single Ubx/Pho co-bound loci revealed that the inability of Pho to remain bound at Ubx/Pho sites in the absence of Ubx resulted in a significant change of H3K27me3 as well as H3K27ac levels at these regions. Thus, we asked whether H3K27me3 and H3K27ac levels were generally altered at Ubx/Pho binding sites when Ubx was depleted in the mesodermal lineage. To this end, we determined H3K27ac and H3K27me3 levels at Ubx/Pho co-bound sites that lost Pho binding when Ubx was degraded. Notably, we did not detect any significant change of H3K27ac and H3K27me3 levels at these sites on the global level, which was also the case for Ubx/Pho co-bound sites that did not experience a change in Pho binding when Ubx was degraded ([Figure 7F](#fig7){ref-type="fig"}). However, a subset of 328 loci, which lost Pho binding and were defined before as regions experiencing histone changes towards activation ([Figure 4D](#fig4){ref-type="fig"}), showed a highly significant loss of H3K27me3 marks (as well as a gain of H3K27ac marks) ([Figure 7F](#fig7){ref-type="fig"}), demonstrating that a substantial number of Ubx/Pho sites required Ubx for stabilizing Pho binding and H3K27me3 marks.

In sum, these results demonstrated that Ubx stabilized Pho binding to chromatin regions at alternative fate genes in the mesodermal lineage, which controlled the proper levels of H3K27me3 and H3K27ac marks, thereby ensuring repression of these genes.

Discussion {#s3}
==========

Cell and tissue types get different during development and their identity needs to be maintained also in adulthood to guarantee the survival of organisms. Here, we provide evidence that multi-lineage TFs of the Hox class stabilize the different lineage choices by restricting cellular plasticity in a lineage specific manner. To this end, we studied the broadly expressed Hox TF Ubx in the mesodermal and neuronal lineages during *Drosophila* development using a comparative genomic approach and an experimental system to deplete Ubx protein exclusively in the embryonic mesodermal lineage. This approach allowed us to dissect the cell-autonomous function of Ubx in a single lineage that was located in an otherwise normal cellular environment at the transcriptome and chromatin level. Using this experimental set-up, we found that Ubx comprehensively orchestrates the transcriptional programs of the mesodermal as well as of the neuronal lineage, as it bound and regulated a substantially fraction of genes specifically expressed in these tissue lineages. Strikingly, this analysis revealed that the majority of Ubx chromatin interactions were located in the vicinity of inactive genes, and lineage-specific interference with Ubx in the mesoderm demonstrated that about 20% of these interactions were important for repressing the close-by genes. Intriguingly, these genes were highly enriched for alternative cell fates, demonstrating that Ubx had indeed a pivotal role in restricting the developmental potential of cell and tissue types in a context-dependent manner.

One important question arising from this result was why not more of the inactive genes bound by Ubx were de-repressed in the absence of Ubx. There are several explanations for this finding. First, Hox TFs cross-regulate each other's expression, a phenomenon described as posterior suppression ([@bib70]; [@bib100]). Consistently, the *Hox* gene *Antennapedia* (*Antp*), which is normally expressed anterior to Ubx, is ectopically activated when Ubx function is absent ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}), allowing Antp now to partially take over the function of Ubx in this lineage. Second, gene regulation is tightly linked to the chromatin status at promoter and enhancer regions. It had been shown in mammalian cells that the turn-over rates of the histone variant H3.3 at regulatory regions were correlated with specific histone modifications, high turn-over when associated with high levels of active histone modifications, like H3K27ac, while much slower turn-over when associated with higher levels of H3K27me3 marks ([@bib47]). This implies that the 'clearing' of repressive histone modifications takes much longer in comparison to active ones. Third, H3K27me3 marks serve as epigenetic memory to permanently silence genes in the course of development, and a recent study demonstrated that a resetting of the epigenetic status requires cell division to dilute the H3K27me3 mediated silencing effect ([@bib18]). In line with these studies, we found that the reduction of H3K27me3 levels was low in comparison to the increase of H3K27ac levels in Ubx depleted mesodermal nuclei. Thus, a de-repression of genes might require either more time or cell divisions or both. However, after its specification at embryonic stage 12 the mesoderm does not divide anymore, which might prevent an efficient clearing of H3K27me3 marks at Ubx targeted chromatin sites. Fourth, de-repression of genes is not only a consequence of abolishing repression but also of gaining activation, which not only requires a change of the histone environment at control regions but also the expression and action of the proper sets of TFs. Comparing the transcriptomes of the mesodermal and neuronal lineages revealed that only about 5% of the TFs expressed in an alternative lineage, in this case the neuronal one, were expressed in the Ubx depleted mesodermal cells, including vnd, HGTX, ham and Ptx1, which was obviously not sufficient to induce a lineage switch, in particular as the expression of only about 10% of the mesodermal fate related TFs was reduced in their expression. As we find Antp to be ectopically expressed in the mesodermal lineage in the absence of Ubx ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}), we assume Antp to partially take over the lineage-specific function of Ubx. Thus, it will be interesting in future to study mesoderm development in a Hox-free environment and determine the fate of the developing cell lineage.

Another highly relevant finding of our study is that the Hox TF Ubx lineage-specifically repressed the transcription of alternative fate genes by organizing the epigenetic landscape and that chromatin changes at Ubx sites were dependent on the interaction of Ubx with the Polycomb recruiter Pho ([@bib34]; [@bib94]). Strikingly, our study revealed that Ubx was crucial for stabilizing binding of the PcG protein Pho to specific chromatin regions. Although it is known that DNA binding TFs other than Pho interact with PREs, for example Grainyhead ([@bib41]; [@bib73]), a TF that has been shown recently to lineage-specifically displace nucleosomes at enhancers ([@bib38]), these studies were mostly performed in vitro and the role of these TFs in Pho chromatin targeting was not addressed ([@bib74]). In contrast, we analysed the combinatorial interaction of Ubx and Pho on the chromatin in vivo, in the mesodermal lineage of *Drosophila* embryos. Importantly, we showed that Pho was no longer able to interact with Ubx bound sites when Ubx protein was depleted in a lineage-specific manner, while Pho-only chromatin interactions were unaffected. As a result, H3K27me3 levels were reduced and H3K27ac levels increased, resulting in the de-repression of genes primarily associated with Ubx-Pho chromatin regions. This result indicated that not only Pho but very likely the whole PcG protein complex was not properly targeted to Ubx chromatin sites, which is in line with our finding that H3K27me3 levels were generally decreased at enhancers of genes de-repressed upon Ubx depletion ([Figure 8](#fig8){ref-type="fig"}). However, we also found H3K27ac levels increased at Ubx chromatin interactions located in the vicinity of de-repressed genes. Interestingly, PREs frequently co-localize with response elements for Trithorax group (TrxG) proteins ([@bib44]), a large group of proteins first described for their role in transcriptional activation. In this line, we identified not only the binding motif for Pho but also for the GAGA TF Trithorax-like (Trl) enriched among the Ubx bound and H3K27me3 marked chromatin sites, and we found Trl to interact with Ubx *in cellulo* ([Figure 8---figure supplement 1F](#fig8s1){ref-type="fig"}). Trl was initially discovered to activate transcription, in particular of the *Ubx* gene ([@bib10]), but is also required for transcriptional repression, as it binds PREs ([@bib37]) and physically associates with the Polycomb Repressive Complex 1 ([@bib83]). Interestingly, Trl had been suggested recently to function as a pioneer factor in early *Drosophila* development by making genomic regions accessible through the deposition of active histone marks. Furthermore, it had been shown that another TrxG protein, the methyltransferase Trithorax (Trx), mediates together with the p300/CREB-binding protein (CBP) the deposition of H3K27ac marks ([@bib106]; [@bib105]), a histone mark that was enriched at promoters and enhancers upon Ubx depletion. Thus, the TrxG complex and CBP could be recruited in the absence of Ubx to activate gene expression ([Figure 8](#fig8){ref-type="fig"}). GAGA factors like Trl do not only play a role in the activation but is also in the repression of gene expression by interacting with the Polycomb complex ([@bib37]; [@bib72]). Interestingly, a recent study showed that GAGA factors are required for the formation of repressive chromatin loops in Polycomb domains to stabilize gene silencing during early *Drosophila* development ([@bib75]). These results could explain one puzzling result of our study, the increase of H3K27me3 marks in the absence of Ubx, which could be due to Trl interacting with these sites when Ubx levels drop ([Figure 8](#fig8){ref-type="fig"}), thereby promoting or increasing the formation of repressive chromatin loops. In future, it will be important to study TrxG as well as PcG proteins at Ubx targeted control regions to understand how Hox TFs orchestrate the interplay between transcriptional activation and repression in the course of lineage development when cellular plasticity needs to be restricted.

![Model of Ubx and Pho combinatorial action in mesoderm development.\
(**A, B**) Chromatin regions close to genes encoding different lineage functions are shown in mesodermal (green) and neuronal (purple) wild-type cells before (**A**) and after (**B**) Ubx is expressed. (**A**) Mesodermal determination and specification factors, like Twist (Twi) and Tinman (Tin), activate mesodermal genes, possibly in combination with Trl (GAGA) and/or other factors. In the same cell, alternative fate genes (grey: ectodermal genes, yellow: gut related genes; purple: neuronal) are repressed, possibly by the mesoderm-specific TF Snail (sna) with Pho and PcG (dark blue). In neuronal determination and specification, TFs like Intermediate neuroblasts defective (Ind) activate neuronal genes, possibly in combination with with Trl (GAGA), while alternative fate genes (grey: ectodermal genes, yellow: gut related genes; green: mesodermal) are repressed, for example via Ventral nervous system defective (Vnd) and Pho and PcG (dark blue). (**B**) When Ubx expression starts, determination and specification factors are turned off or their expression gets restricted. Now, Ubx ensures the continued activation of the proper set of lineage-specific genes, while at the same time maintaining the repression of alternative fate genes. (**C, C'**) Loss of Ubx in the mesodermal lineage destabilises Pho binding to regulatory regions of alternative fate genes (example for neuronal (purple)). (**C**) This results in a destabilisation of the PcG complex at these regions, leading to a loss/reduction of H3K23me3 marks. (**C'**) In the absence of Ubx and PcG, the sites can be bound by the TrxG complex through Trl (GAGA) in combination with CBP. Consequently, Lys 27 of histone three at these regions will get acetylated, resulting in the activation of gene expression.](elife-42675-fig8){#fig8}

An important question arising from this study is how Hox TFs can function so specifically in different tissue lineages, as they activate a gene set in one lineage while repressing it in another one. One explanation is that tissue/lineage restricted factors and their interaction with Hox TFs provide specificity. Interestingly, we find the binding motif for the mesoderm-specific TF Snail (Sna) enriched among the sites, which are bound by Ubx and marked by H3K27me3 in the mesodermal lineage, while in the neuronal lineage the Ventral nervous system defective (Vnd) motif is frequently found in Ubx/H3K27me3 sites. Motifs for tissue-specific TFs are also detected at active sites, as Ubx/H3K27ac regions in the mesoderm have the Slouch (Slou) motif enriched, while in the nervous system it is the motif for Intermediate neuroblasts defective (Ind). Thus, we assume these factors to be critical in determining the lineage-specific output ([Figure 8](#fig8){ref-type="fig"}). In future, it will be interesting to study these tissue-restricted interactions and determine their role in the lineage-specific repression and activation of developmental gene programs.

One peculiar feature of Hox TFs is that they are not only active during the development but their input is continuously required throughout the lifetime of an organism to assess the positional values of cells and to maintain their proper identities and functions ([@bib3]; [@bib17]; [@bib28]; [@bib53]; [@bib71]; [@bib79]; [@bib78]). Our findings now shed new light on the mechanism ensuring this stability in cellular identity, as they suggest that Hox TFs robustly repress alternative lineage programs (via the interaction with epigenetic factors like Pho) and reliably restrict the developmental potential encoded cells. In the normal context, this is absolutely critical for an organism to function properly, however, in some instances it can be a major hurdle, in particular when cells need or should adopt a new identity, which requires them often to regain plasticity. In organismal life, this happens mostly during dedifferentiation, regeneration and tissue remodelling ([@bib65]; [@bib68]; [@bib92]). Another situation of cell type conversion is cellular reprogramming, which is extensively studied due to its high potential as therapeutic strategy ([@bib57]). But although reprogramming strategies have been improved over time, the direct conversion of one somatic cell type into another one, the so-called transdifferentiation, is still inefficient ([@bib23]; [@bib62]). Interestingly, it has been reported recently that the induction of the Hox code typical for a differentiated cell type in pluripotent stem cells (PSCs), either in combination ([@bib101]) with other factors or even alone ([@bib98]), can convert PSCs into the cell type expressing the Hox code in vivo. This clearly shows that *Hox* genes can effectively induce cell type specific transcriptional programs in multi-potent cells thereby unambiguously inducing their differentiation. This is in line with our findings showing that Hox TFs activate lineage-specific transcriptional profiles with high precision. However, so far it is unclear why the conversion of somatic cells of one type into another one is so difficult. Our data now suggest that one reason for this hurdle could be the Hox encoded restriction of cellular plasticity via the repression of alternative gene programs using Polycomb based epigenetic mechanisms.

Materials and methods {#s4}
=====================

Fly stocks and husbandry {#s4-1}
------------------------

For the INTACT method ([@bib99]) the following fly lines were used: *twi-INTACT* and *UAS-INTACT* (gift from the Henikoff lab). The *UAS-INTACT* was crossed in the *elav-GAL4* background to generate *elav-GAL4;;UAS-INTACT* stable lines. For the degrade GFP experiments ([@bib16]) the following lines were used: *arm-GAL4* (BL1561) *Mef2-GAL4* (BL50742), *UAS-TEV-P14* (homemade using the construct published in Taxis et al., 2009, insertions were performed by BestGene at attP5 and attP2). *UAS-Nslmb-vhhGFP4* (BL38419), the *GFP-Ubx^3.005^* line was recombined with the *UAS-Nslmb-vhhGFP4* and *Mef2-GAL4* lines and crossed in the *twi-INTACT* background to generate *twi-INTACT;Mef2-GAL4,GFP-Ubx^3.005^* and *twi-INTACT; UAS-Nslmb-vhhGFP4,GFP-Ubx^3.005^*. Embryos from Ubx deGradFP experiments were collected at 10--18 hr AEL to ensure the knockdown of the GFP-Ubx protein. The *pho-like^81A^;pho^1^* douple mutant was generously provided by Jürg Müller ([@bib46]). The *dpp-lacZ* line was obtained from Manfred Frasch.

Generation of endogenously tagged Ubx {#s4-2}
-------------------------------------

The *GFP-Ubx^3.005^* line was generating by using the CRIPR/Cas9 system ([@bib6]; [@bib32]). For the donor DNA a pUC-MCS-5'GFP-MCS was designed, multiple cloning sites flanking the GFP containing an ATP start codon. For the 5' region from the GFP a homologous arm ([@bib5]) containing the 5'UTR was cloned by using Not*I* and Kpn*I* restriction sites. The 3' region from the GFP included the first Ubx exon and a large part of the intron for homologous recombination was cloned with Bgl*II* and Xho*I*. The gRNAs were designed to eliminate the first Ubx exon, positioned at the beginning of the 5'UTR and the end of the coding region of the first exon. The excised exon was replaced using the donor DNA and homologous recombination. The microinjection was performed by BestGene using *vas-Cas9* (BL51323) as injection line and the resulting progenies (F0) were crossed with TM3/TM6 balancers and resulting F1 was used for single crosses against TM3/TM6 balancers to generate independent stocks. The F1 generation was screened by PCR for the presence of the GFP and the GFP containing stocks of the F2 generation were visually screened for the Ubx patterned GFP expression in vivo.

Generation of the Ubx antibody {#s4-3}
------------------------------

The Ubx antibody was generated using the pGEX-purification system (GElifesciences). The open reading of Ubx-RA was cloned in the pGEX-6P-2 vector using Bam*HI* and Xho*I* restriction site. The protein was purified according to the protocol (GElifesciences) and eluted by using the PreScission Protease site. The immunisation and antibody handling were performed by the Charles Rivers company.

Purification of affinity-tagged nuclei, ChIP, ChIP-Seq and RNA-Seq {#s4-4}
------------------------------------------------------------------

The nuclei were purified as described in [@bib99], the purification was optimised by using a larger magnet (20cm x 20cm x 10cm, holding 70 kg) and a homemade magnet holder (gift from C Schaub and M Frasch). For ChIP and ChIP-Seq experiments: Chromatin preparation and immune-precipitation were performed as described in [@bib91]. The following antibodies were used: H3K27ac (ab4729, Abcam), H3K27me3 (ab6002, Abcam), Rb-Pho^2-382^ (generously provided by J. Müller) and the homemade guanine pig Ubx antibody (gp-Ubx). Total RNA was isolated with TRIZol (Invitrogen) and DNA digest was performed with the TURBO DNA-free Kit (Ambion). The material was analysis or validated by qPCR (Invitrogen Syber-Green-Mix) ([Supplementary files 2](#supp2){ref-type="supplementary-material"}, [3](#supp3){ref-type="supplementary-material"}). Genome-wide sequencing and material handling was performed in tight cooperation with the Deep-Sequencing facility in Heidelberg. The library for genome-wide sequencing was prepared by using the ThruPLEX DNA-Seq Kit (Rubicon) for illumina sequencing.

Bioinformatics analysis {#s4-5}
-----------------------

### ChIP-Seq {#s4-5-1}

1\) Ubx binding events in wild-type nuclei: ChIP-seq experiments were performed at least in biological duplicates. 2) Pho binding, H3K27ac and H3K27me3 marks in Ubx degradation nuclei: ChIP-seq experiments were performed in biological triplicates (control, experiment). The reads were first analysed with FastQC and aligned with bowtie2 (`bowtie2 --very-sensitive -x Bowtie2Index/genome sequence.txt -S output.sam` \[[@bib51]\]) against the dm6 Drosophila genome version using standard conditions, the peaks were called by using MACS2 under model-based broad settings (`macs2 callpeak -t IP-file.sam -c input-file.sam -f SAM -n < name > broad -g dm --keep-dup auto -B --broad-cutoff 0.1 3`). Wild-type reads were tested for their similarity by person correlation and the two most similar were combined using samtools for further analysis. The annotation of wild-type peaks was performed using ChIPseeker ([@bib111]), ChIPpeakAnno ([@bib115]) and the *Drosophila* genome dm6. Annotations were not filtered for 'real' coding genes and all FBgnNumbers were used for further analysis. Identification of differential Histone and Pho Binding events were identified with DiffBind ([@bib88]), statistical relevant regions were isolated with BEDtools (bedtools intersect; [@bib84]). For GO-Term annotations and overrepresented GO-Term analysis was performed with the web-tools bioDBnet and PANTHER (GO biological function complete, Binomial, Bonferroi correction \[[@bib104]\]). Promoter and enhancer definition is related to [@bib95] and [@bib25].

### Statistical analysis of specific regions {#s4-5-2}

Regions of interest were isolated and bed fines generated. The regions were compared with results from DiffBind using bedtools intersect ([@bib84]) or full reads of the control and Ubx^deGrad^ using bedtools coverage ([@bib84]). Violin plots were calculated using R.

### Motif search {#s4-5-3}

The motif search on defined regions was done by using the MEME-suite web-tool ([@bib29]) or the command line (`meme-chip -db motif_databases/FLY/OnTheFly_2014_Drosophila.meme -meme-minw 6 -meme-maxw 20 -meme-nmotifs 100 -centrimo-local -centrimo-maxreg 250 seq.fa`). Enrichment of known motifs was performed with a AMT MEME tool (`ame --verbose 1 oc. --control shuffled_overlaps_onlyPho_ME_2.fa --bgformat 1 --scoring avg --method ranksum --pvalue-report-threshold 0.05 file.fa db/FLY/fly_factor_survey.meme db/FLY/idmmpmm2009.meme db/FLY/flyreg.v2.meme db/FLY/OnTheFly_2014_Drosophila.meme db/FLY/dmmpmm2009.meme`).

### Comparison of Ubx, Tin and Mef2 {#s4-5-4}

The Tin data set from [@bib39] and the Mef2 data set from [@bib90] was used, the Ubx data sets for the mesoderm were realigned against the *Drosophila* genome dm3 using bowtie and the peaks were newly called using MACS2.

### Analysis of Ubx and Pho ChIP-Seq data {#s4-5-5}

The Pho data set was obtained from [@bib25] and processed as decried above for Ubx against dm6. Genomic overlaps were performed with ChIPseeker ([@bib111]) and ChIPpeakAnno ([@bib115]).

### RNA-Seq {#s4-5-6}

1\) wild-type: RNA-seq experiments were performed in biological duplicates. 2) Loss of Ubx function experiments: RNA-seq experiments were performed in biological triplicates. Obtained RNA reads were first analysed with FastQC and aligned with TopHat2 ([@bib43]) (`tophat2 -p 8 G Drosophila_melanogaster.BDGP6.86.gtf -o output_folder_name BDGP6_86 converted_sequence.fastq`) against the BDGP6_86 Drosophila genome version using default settings (BDGP5_75 for all comparisons against dm3). The count table for further analysis was generated using HTSeq (`htseq-count -f bam -r pos -m union -s no -t exon accepted_hits.bam Drosophila_melanogaster.BDGP6.86.gtf>counts.txt` \[[@bib2]\]). The differential expression analysis was performed by using DESeq2 ([@bib59]). The overrepresented GO-Term were analysed with PANTHER (GO biological function complete, Binomial, Bonferroi correction). The general tissue-specific transcriptome was generated by using a general calculation of the RPKM (Equation: RPKM = (109 \* number of reads mapped to a gene)/Total mapped reads in the experiment \* exon length in base-pairs for a gene)). Genes containing a RPKM \>5 were classified as transcribed according to ([@bib20]; [@bib49]).

Visualisation of the genome-wide data {#s4-6}
-------------------------------------

Preparation of the data for visualisation was performed with deeptools: `Normalization computeGCBias -b file_sorted.bam --effectiveGenomeSize 142573017 g dm6.2bit -l 250 --GCbiasFrequenciesFile file_freq.txt --biasPlot file_test_gc.pdf` and `correctGCBias -b file_sorted.bam --effectiveGenomeSize 142573017 g dm6.2bit --GCbiasFrequenciesFile file_freq.txt -o file_gc_corrected.bam`. The samples were normalized to the input to generate the bigwig file `bamCompare -b1 sample_gc_corrected.bam -b2 input_gc_corrected.bam -o file_S-I_100_subtract.bw --scaleFactorsMethod None --operation subtract --binSize 10 --effectiveGenomeSize 142573017 --normalizeUsing RPKM --smoothLength 100 --centerReads --extendReads 150`. The reads and annotations were visualised with IGV.

Interactive data mining tool {#s4-7}
----------------------------

The enrichment analysis method presented in this paper is implemented as a user-friendly Shiny web-application accessible via <http://beta-weade.cos.uni-heidelberg.de>. The user can select the set of genes to perform the GO enrichment analysis and the respective background independently. Results of the analysis are presented as a plot, an interactive table displaying significantly enriched GO groups, and an interactive heatmap, showing the counts of enriched GO terms within the respective higher-order GO group. It is also possible to get an insight into the individual GO terms that make up a category and into the genes that contributed to the categories or terms. The functionality of the tool exceeds what is described here, a detailed documentation of the tool is deposited under <http://beta-weade.cos.uni-heidelberg.de> and additionally an interactive guide is provided in the online application.

Multiple testing of GO-terms {#s4-8}
----------------------------

Pre-set list of GO-terms related to mesoderm and muscle development and function (mesoderm), neuronal and central nervous system (CNS) and neuromuscular junction development and function (neuronal), ectoderm and trachea development and function (ectoderm) and endoderm development and gut structures (salivary glands, Malpighian tubes, hind- and foregut) and function (gut and endoderm) was generated ([Supplementary file 4](#supp4){ref-type="supplementary-material"}). Genes associated with different categories were analysed using an R program based on a biomaRt script ([@bib22]).

Immunofluorescence staining and microscopy {#s4-9}
------------------------------------------

### Nuclei staining {#s4-9-1}

INTACT-sorted nuclei were collected by centrifugation at 1000 g for 5 min and resuspend in the suitable amount of HB125 ([@bib99]) +5% BSA for the antibody staining according to the conditions of the 1^st^ antibodies and incubated over night at 4°C, than washed 3 times 15 min with HB125 and incubated in 500 µl HB125 +5% BSA for the 2^nd^ antibodies (2^nd^ ABs 1:500). Before mounting, nuclei were washed 3 times 15 min with HB125. Embryonic stainings were performed as described in [@bib21] and the following antibodies were used: Rb-Mef2 (1:1500, Gift from H. Nguyen), Rat-elav (1:50, DSHB, ELAV-9F8A9), Rat-Tm1 (1:200, MAC-141, ab50567, Abcam), Rb-GFP (1:300, Invitrogen), Rat-GFP (1:100, ChromoTek), DAPI (1:500, Invitrogen), Rat-Org1 (1:100) ([@bib92]), Rb-Pho (1:250) ([@bib46]), Ptx1 antibody (1:1000) ([@bib108]), ms-Antp (1:100, DSHB, 8C11). Amplification was obtained with the TSA system (Perkin-Elmer). Biotinylated (1:200, Vector Labs) and fluorescent (1:200, Jackson ImmunoResearch) secondary antibodies were used. Images were acquired on the Leica SP9 Microscope using a standard 20x and 63x objective. The collected images were analysed and processed with the Leica program and Adobe Photoshop.

Quantifications of data {#s4-10}
-----------------------

### Quantification of the GFP signal intensity {#s4-10-1}

GFP signal was measured with the Fiji program from at least five segments per embryo in five embryos. The mean and the t-test for significance were calculated in Excel.

### Quantification of histone marks {#s4-10-2}

Regions of interest (Ubx bound regions with histone mark changes that are up-regulated or without up-regulation, Ubx and Pho bound regions, Ubx Pho and active regions) were identified and compared with the deGrad-DiffBind results, histone binding peaks from control or deGrad-data sets by using bedtools intersect or bedtools coverage. The isolated Fold or peak depth were illustrated in a Violin plot with R, as well as the wilcoxon rank test for significance. Fold changes required for ratio calculation were processed with an R-script (upon request) and illustrated in a Violin plot with R, as well as the Wilcoxon rank test for significance.

Protein IP, CoIP and Western Blot {#s4-11}
---------------------------------

### Embryonic Protein IP {#s4-11-1}

The GFP-Ubx protein was immune precipitated from whole mount embryos by using GFP-tap-beads (ChromoTek). Collected Embryos were washed and smashed in IP Buffer (50 mM Tris-HCl, pH 8.0; 1 mM EDTA; 0.5% (v/v) Triton X-100, 1 mM PMSF, Complete proteinase inhibitors (ROCHE). For immunoprecipitation 1 mg of total protein was incubated over night with IP Buffer washed GFP-tap-beads. Beads were then washed 3x with IP Buffer and resuspended in Laemmli buffer.

### Cell culture CoIP {#s4-11-2}

S2R + Drosophila cells were cultured in Schneider medium supplemented with 10% FCS, 10 U/ml penicillin and 10 µg/ml streptomycin. For plasmid transfections, 10.10^6^ cells per ml were seeded in 100 mm dishes and transfected with Effectene (Qiagen) according to the manufacturer's protocol. Cells were harvested in Phosphate Buffered Saline (PBS) and pellets were resuspended in NP40 buffer (20 mM Tris pH7.5, 150 mM NaCl, 2 mM EDTA, 1% NP40) supplemented with protease inhibitor cocktail (Sigma-Aldrich) and 1 mM of DTT. For co-immunoprecipitation assays 1 mg to 1.5 mg of proteins were incubated for 3 hr with 15 µl of GFP-Trap beads (Chromotek). Beads were then washed 3 times with NP40 buffer and finally resuspended in Laemmli buffer for immunoblotting analysis. Input fractions represent 2.5% of the immunoprecipitated fraction.

### Embryonic CoIP {#s4-11-3}

Overnight collection of embryos was dechorionated, fixed with 3.2% formaldehyde and collected in Phosphate Buffered Saline (PBS) supplemented with Tween 0.1%. Pellets were resuspended in buffer A (10 mM Hepes pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol) and dounced 25--30 times with loose- and 5 times with tight- pestle. Lysates were incubated with 0.1% Triton and centrifugated. Nuclear pellets were then resuspended with buffer B (3 mM EDTA pH8, 0.2 mM EGTA pH8), sonicated (Picoruptor, Diagenode), and treated with Benzonase (Sigma). For co-immunoprecipitation assays 4 to 5 mg of nuclear lysates were diluted in NP40 buffer (20 mM Tris pH7.5, 150 mM NaCl, 2 mM EDTA, 1% NP40) and incubated overnight with 40 µl of GFP-Trap beads (Chromotek). Beads were then washed 5 times with NP40 buffer and resuspended in Laemmli buffer for immunoblotting analysis. All buffers were supplemented with protease inhibitor cocktail (Sigma) and 1 mM of DTT and 0.1 mM PMSF. Input fractions represent 2.5% of the immunoprecipitated fraction.

For western blot analysis, proteins were resolved on 10% SDS-PAGE, blotted onto PVDF membrane (Biorad) and probed with specific antibodies after saturation. The antibodies (and their dilution) used in this study were: Ubx (home-made, 1/200), Pho (generously provided by Jürg Müller, 1/500 \[[@bib46]\]), Histone 3 (ab1791, Abcam, 1/10000), GFP (A-11122, Life Technologies, 1/3000).
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Thank you for submitting your article \"The Hox Transcription Factor Ubx stabilizes Lineage Commitment by Suppressing Cellular Plasticity\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Kevin Struhl as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Bart Deplancke (Reviewer \#2).

The reviewers have discussed the reviews with one another, at length, and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Overall, the reviewers were enthusiastic about the subject and the approach, and they found the conclusions interesting and noteworthy. But as you can see from the reviews, which are appended in their entirety below, the reviewers also had substantial reservations about technical aspects of data collection and analysis. One simple issue that all the reviewers were concerned about was the lack of replicates for the ChIP experiments (3 replicates are standard), and they agreed that 2 or preferably 3 replicates should be performed and the data re-analyzed. A second general concern was the ChIP-PCR data indicating that Ubx controls H3 K27me3 distributions and Pho binding; in this case the reviewers agreed that the Pho ChIP samples +/- Ubx-deGrad (Figure 6) should be sequenced, to better substantiate your interesting conclusions using whole genome data. (In principle, the H3 K27me3 ChIP samples in Figure 6 should likewise be sequenced, though we leave it up to you to decide how important it is.) Thirdly, we would like to see a few changes to the data analysis, as described in the reviews, to bring into line with standards in the field. Clearly these additional experiments will require some investment, but we feel they are necessary to the bring to paper up to accepted standards in the field. We look forward to seeing your revision.

*Reviewer \#1:*

The Lohmann lab presents an extremely complex analysis of the role of the Hox transcription factor Ubx in lineage commitment/specification in *Drosophila*. In order to remove Ubx from a given lineage only, they used a protein degradation method recently established and an endogenously tagged version of Ubx. The study is elegant in its design, and many of the discussed findings appear to provide interesting insight into the role of Ubx in the mesoderm, and possibly beyond.

However, for a non-expert in such genome-wide approaches, both the experimental and the analytical part of the work are difficult to analyse and evaluate in detail. In light of this fact, I have to admit that I found the work very interesting, timely and novel, and certainly of excellent quality and relevance to be published in *eLife*. Even after having read the paper three times, I have not seen any reason to ask for additional experiments.

*Reviewer \#2:*

Using the INTACT nuclei isolation method coupled to comprehensive RNA-seq and ChIP-seq assays, Domsch and colleagues found that a Hox class transcription factor (TF) Ubx binds to both active genes and inactive genes linked to either the mesodermal or neuronal lineages. The authors therefore hypothesized that Ubx may function in tissue development as a repressor of alternative transcriptional programs (i.e. programs steering cells toward a distinct differentiation fate). To investigate this postulate, the authors studied the regulatory function of Ubx in different lineages by depleting this TF in a tissue-specific manner. These experiments revealed that a large proportion of alternate fate genes are upregulated once Ubx is removed, in line with their hypothesis. The authors further profiled the H3K27ac and H3K27me3 chromatin landscapes in Ubx-depleted tissues, which revealed that Ubx likely represses alternate fate genes by controlling their epigenomic status, especially K3K27me3 enrichment. Subsequent motif analysis and downstream experiments thereby showed that this repressive chromatin mark may be directed toward these loci through the regulator Pho, which is stabilized by Ubx at these repressed regions.

Together, this is a very interesting study that should be of broad interest to the gene regulation and developmental biology fields given the formulation of a novel mechanistic model that rationalizes how a broadly expressed TF is able to contribute to cell lineage specification by repressing alternate cell fate genes. The techniques applied, such as tissue-specific nuclei isolation, tissue specific Ubx gene tagging/depletion are elegant and state of the art and the resulting data seems in general solid. There are only a few items that could be clarified better:

1\) The authors used 10 RPKM as their threshold to distinguish active from inactive genes. This is a rather high threshold, and so one is left to wonder what the consequence would be on the downstream analyses/results if the more standard threshold of 1 RPKM would be applied?

2\) The authors show that Ubx binds to a very large number of genes (roughly 10 K based on Figure 2B, and thus \>70% of all *Drosophila* (10 K / 14 K) can be considered to be Ubx targets). This raises a couple of questions:

a\) In Figure 2B, the number of Ubx-bound genes in neuronal tissue at stages 14-17 is much lower than for the other three conditions. What could be the underlying reason?

b\) In Figure 2G, the authors show that there is a high correlation in higher order GO terms between the lineage specific transcriptional and Ubx binding profiles. As a control, the authors included the TF Tinman, which revealed a more distinct GO term enrichment profile. However, since Ubx binds to such a large number of genes, is it not entirely expected that the majority of active genes will also be Ubx targets, and thus yield the same GO term enrichment profile? The same holds true for the inactive genes which also fall mostly within the \"Ubx target space\" and would thus again yield the same profile. That Tin does not yield the same profile is also not surprising given that it binds much fewer genes so the overlap between (in)active genes and Tin gene targets will be much smaller. A better control (if available) would in this regard be a TF that, similar to Ubx, binds to a large number (10 K) of genes. In its current configuration however, this analysis is not very informative. Similar concerns apply to the statements \"Strikingly, 85% (1227/1452) of the genes with reduced and 90% (1299/1393) of the genes with increased expression were bound by Ubx in mesodermal nuclei in wild-type embryos, implying that most of the expression changes were a direct consequence of altered Ubx chromatin interactions\". Again, since \>70% of *Drosophila* genes are Ubx targets, 85-90% is in fact not very striking and could just be a statistical aberration. This needs to be addressed.

3\) The proposed model, while informative, is too simplistic. This is because, in its current form, the model lacks information on what the factors / determinants are that mediate either tissue-specific activation or repression. The identification of these factors is likely beyond the scope of the current study, but perhaps some first layer data analysis on motifs (beyond the listed generic ones) could be performed. In addition, these additional layers need to be incorporated in the model because, as an example, the Ubx-Pho complex is shown to repress neuronal genes in the mesoderm given the enrichment of the Pho motif in these repressed genes. But why then, given that the same motif will obviously be present in the DNA of a neuronal cell, does Pho-Ubx not repress these same genes in a neuronal cell (also since both Pho and Ubx are ubiquitously expressed)? What makes that the Pho motif in a neuronal cell is read differently in a mesodermal cell and vice versa? The same reasoning can be followed for active genes in the respective cell types. At a minimum, such uncertainties should be represented in the model to clearly indicate what type of regulatory information is still missing.

*Reviewer \#3:*

I have mixed responses to the paper by Domsch et al. On the one hand, the experimental design, to analyze Hox regulatory mechanisms in distinct embryonic tissues, seems at first glance important and exciting, I was less impressed with the analysis than I expected to be. My concerns fall in two categories:

1\) Data generation and analysis.

For one, although replicates were analyzed for the RNA-seq experiments, it seems that all of the ChIP-seq datasets were only done once, without replicates. Given how noisy these type of data can be (especially when working with a small number of sorted cells and weak ChIP signals as in this case) I think it is imperative to compare at least two experimental replicates and use peak calling algorithms that require two independent datasets to assess statistical relevance. The Venn diagrams in Figure 2---figure supplement 1 for example suggest that there are \~14,000 (!) Ubx peaks in the mesoderm and that more than 7000 of these are mesoderm-specific. These numbers are quite striking but as it stands it is not possible to know how solid they are without replicate datasets and rigorous statistical tests.

I also wonder about the way the authors subtract input ChIP signals from their experimental IPs, as this is an analysis method that is not typically seen in the literature. I would like to see how noisy the input IPs are \-- those tracks should be shown.

There is little validation of the ChIP peaks. The only known enhancer that was highlighted was one from Dpp.

The Pho co-IP signal is surprisingly weak given the mechanism of co-recruitment that the authors are proposing.

GAGA-like motifs are often observed by motif discovery algorithms and I am not convinced they are meaningful here given the lack of solid follow up evidence.

One potential strength of the paper is the claim that Pho binding and K27me3 depends on Ubx binding. However, this conclusion is based on a small handful of loci analyzed by qPCR and the differences are small. Further, given that the Pc system can have very specific targets, I think that calculating the ratio of K27me3/K27ac can be misleading. Better to treat these marks independently, since when one is lower it isn\'t necessarily the case that the other will be higher. It is also the case that Pho binding is not equivalent to K27me3; the latter could simply be a consequence of whether the gene is repressed, which may or may not occur in a Pho-dependent manner.

Many genes lose expression in the Ubx knockdown experiments, suggesting that Ubx also acts as an activator in the mesoderm, but this is not adequately discussed or studied in the paper. It is not clear why the authors choose to focus on the repressed genes.

2\) General comments.

Ubx, and Hox genes in general, are well studied transcription factors that are known to be important in multiple cell types including mesoderm, the nervous system, and epithelium. So, seeing lots of genes change their expression when a broadly used transcription factor like Ubx is knocked down. It is also not surprising that the genes differ depending on the tissue (thus the GO analyses done in this paper seems rather trivial). What would take the analyses beyond what is known already is to understand how Ubx carries out differential functions in these two (and other) tissues. Presumably this happens in conjunction with tissue specific factors (e.g. twist for the mesoderm). The role of lineage specific factors, however, is not addressed and only marginally mentioned in the paper.

Terms such as \"Cell plasticity\" and \"lineage restriction\" are used rather loosely. The authors show that many up-regulated genes after Ubx knockdown are expressed in other lineages, but this result would have to be the case when a TF that represses genes is removed. There is no hard-evidence of lineage conversion (like loss of mesodermal master-regulatory factors for example), nor is it clear why neuronal (as opposed to endodermal or epithelial genes) genes are the focus here. It seems that the analysis is artificially restricted to repressed neuronal genes, while a more unbiased analysis of the changes that occur would be more valuable.

10.7554/eLife.42675.034

Author response

> Overall, the reviewers were enthusiastic about the subject and the approach, and they found the conclusions interesting and noteworthy. But as you can see from the reviews, which are appended in their entirety below, the reviewers also had substantial reservations about technical aspects of data collection and analysis.
>
> One simple issue that all the reviewers were concerned about was the lack of replicates for the ChIP experiments (3 replicates are standard), and they agreed that 2 or preferably 3 replicates should be performed and the data re-analyzed.

We apologize if this was written in an unclear manner, but we had done all experiments of course at least in duplicates. We have now redone the analysis for the Ubx ChIP-seq data, all replicates were tested for similarity by Pearson correlation (0.94 -- 0.96) and we used two replicates with highest similarity for further analysis. This is now clearly written in the revised version.

The experiments in the Ubx degradation background were performed in three biological replicated, for the control (twi-INTACT; GFP-Ubx, UAS-Nslmb) and the experiment (twi-INTACT; *Mef2*\>UAS-Nslmb,GFP-Ubx). For the analysis of differential Expression (RNA-Seq, DESeq) and differential Binding (ChIP-seq, DiffBind) the two most similar replicates were analyzed.

We emphasize this now very clearly in the main text as well as in the Materials and methods section.

> A second general concern was the ChIP-PCR data indicating that Ubx controls H3 K27me3 distributions and Pho binding; in this case the reviewers agreed that the Pho ChIP samples +/- Ubx-deGrad (Figure 6) should be sequenced, to better substantiate your interesting conclusions using whole genome data. (In principle, the H3 K27me3 ChIP samples in Figure 6 should likewise be sequenced, though we leave it up to you to decide how important it is.)

We have performed the requested Pho ChIP experiments in the UbxDegrad and control and sequenced everything in three biological replicates. The data is now included in the manuscript and shown in Figure 7.

> Thirdly, we would like to see a few changes to the data analysis, as described in the reviews, to bring into line with standards in the field.

We have performed the requested analyses and describe them in the specific points to the reviewers (in particular reviewer \#3).

Reviewer \#2:

> \[...\] 1) The authors used 10 RPKM as their threshold to distinguish active from inactive genes. This is a rather high threshold, and so one is left to wonder what the consequence would be on the downstream analyses/results if the more standard threshold of 1 RPKM would be applied?

We thank the reviewer for this comment. The usage of such a stringent threshold was based on previous studies, which had used similar RPKMs, in particular when studying tissue-specific gene expression (for example Dezso Z, ... Nikolskaya, BMC Biology, 2008). In addition, other studies using the INTACT procedure and thus profiling nuclear and not whole cell RNAs used a similar stringent threshold to reduce the false positive recovery rate (for example, Reynoso et al., 2019). We do understand the reviewer's concerns, thus we have re-analyzed the data using a threshold of \>5 RPKM, which is frequently used (Dezso et al., 2008, Chen et al., 2013, reviewed Kryuchkova-Mostacci and Robinson-Rechavi, 2016). As the reviewer will appreciate, this does not change the results and the main take home message of the manuscript.

> 2\) The authors show that Ubx binds to a very large number of genes (roughly 10 K based on Figure 2B, and thus \>70% of all Drosophila (10 K / 14 K) can be considered to be Ubx targets). This raises a couple of questions:
>
> a\) In Figure 2B, the number of Ubx-bound genes in neuronal tissue at stages 14-17 is much lower than for the other three conditions. What could be the underlying reason?
>
> b\) In Figure 2G, the authors show that there is a high correlation in higher order GO terms between the lineage specific transcriptional and Ubx binding profiles. As a control, the authors included the TF Tinman, which revealed a more distinct GO term enrichment profile. However, since Ubx binds to such a large number of genes, is it not entirely expected that the majority of active genes will also be Ubx targets, and thus yield the same GO term enrichment profile? The same holds true for the inactive genes which also fall mostly within the \"Ubx target space\" and would thus again yield the same profile. That Tin does not yield the same profile is also not surprising given that it binds much fewer genes so the overlap between (in)active genes and Tin gene targets will be much smaller. A better control (if available) would in this regard be a TF that, similar to Ubx, binds to a large number (10 K) of genes. In its current configuration however, this analysis is not very informative. Similar concerns apply to the statements \"Strikingly, 85% (1227/1452) of the genes with reduced and 90% (1299/1393) of the genes with increased expression were bound by Ubx in mesodermal nuclei in wild-type embryos, implying that most of the expression changes were a direct consequence of altered Ubx chromatin interactions\". Again, since \>70% of Drosophila genes are Ubx targets, 85-90% is in fact not very striking and could just be a statistical aberration. This needs to be addressed.

We thank the reviewer again for this valuable comment. Concerning the first point: We cannot explain why Ubx binds to less chromatin regions in the late neuronal time point, in particular as the quality of the reads is similar to the other stages. However, we assume that this is due to the different biology of the two lineages. In particular, as we already mention in the text, the neuronal lineage is a bit ahead of the mesodermal lineage with regards to developmental processes and initiates differentiation earlier than the mesoderm. This might result in a reduction of Ubx binding in the neuronal lineage.

The surprising outcome was that Ubx is indeed binding to a lot of sites. This is of course dependent on the TF type, on the way data are analysed, which thresholds are set. As requested by this reviewer before, we reanalyzed the Ubx data sets using a threshold of \>5 RPKM (dm6 *Drosophila* genome), we then identified matching replicated via person correlation and combined the data sets for further analysis. This already changed the number of genes to which Ubx binds. We obtain now 6417 Ubx bound genes at stages 10-13 and 8256 Ubx bound genes at stages 14-17 in the mesoderm, with 80% of them corresponding to coding genes and 20% to non-coding genes. Thus, in total Ubx binds to 37-46% of the genes in the *Drosophila* genome (total number of coding genes in the dm6 genome is 13971) using these settings. Using the WEADE tool, we still see the same result, that Ubx binding reflects genome activity, suggesting that Ubx indeed comprehensively controls lineage development.

We have studied the comparison of Ubx and Tin binding behavior in more detail, as we do agree with the reviewer that the number of bound genes will affect the outcome. For Tin, we had to rely on available mapping data onto the *Drosophila* genome dm3, since the files (bed files) available for Tin (Jin et al., 2013) were done using this version. Alignment and peak calling against dm3 results in regions that are named "U" and "Uextra", which are normally removed as described in the supplementary of Erceg et al., 2017. This led to a removal of nearly half of the mapped reads. Using dm6 as a reference genome, which we did for the Ubx data, maintains these peaks and results in more binding events. In order to make the Ubx and Tin datasets more comparable, we mapped the Ubx peaks against the dm3 genome, which resulted in the identification of only 1914 genes to which Ubx binds in the early mesoderm. This is now comparable to the binding events of Tin in the mesoderm. We then redid the WEADE analysis and still get a very similar result (which we now present in Figure 2---figure supplement 2). In addition, we did the analysis also with another TF, *Mef2*, which generally controls mesoderm development and not like Tin a sub-aspect (cardiac development). Interestingly, we see that Ubx and Medf2 binding profiles are similar, while Tin binding preferences are more different. This makes in our opinion the main message even stronger, as Ubx binding is more similar to a general factor controlling mesoderm development. Thus, we are convinced that this finding reflects true differences between Ubx, *Mef2* and Tin.

We do agree with the reviewer, that in the previous version the use of "striking" was not adequate, and we removed it from the text. Using the reanalyzed data, we now see that about 70% of the genes that were up- or down-regulated were bound by Ubx, and thus are very likely direct targets of Ubx. We would however highlight that binding does not necessarily mean a regulatory function, it is possible that Hox proteins bind without any functional consequences, and this could be a substantial fraction of the Hox binding events (see Biggin and McGinnis, 1997).

> 3\) The proposed model, while informative, is too simplistic. This is because, in its current form, the model lacks information on what the factors / determinants are that mediate either tissue-specific activation or repression. The identification of these factors is likely beyond the scope of the current study, but perhaps some first layer data analysis on motifs (beyond the listed generic ones) could be performed. In addition, these additional layers need to be incorporated in the model because, as an example, the Ubx-Pho complex is shown to repress neuronal genes in the mesoderm given the enrichment of the Pho motif in these repressed genes. But why then, given that the same motif will obviously be present in the DNA of a neuronal cell, does Pho-Ubx not repress these same genes in a neuronal cell (also since both Pho and Ubx are ubiquitously expressed)? What makes that the Pho motif in a neuronal cell is read differently in a mesodermal cell and vice versa? The same reasoning can be followed for active genes in the respective cell types. At a minimum, such uncertainties should be represented in the model to clearly indicate what type of regulatory information is still missing.

We do agree with the reviewer that the factors that mediate the tissue-specific activation and repression are very interesting, but are indeed beyond the scope of this paper. We have however performed some preliminary analysis (motif search) and included this in an extended version of the model shown in Figure 8A and B. We have also now dedicated a section to the Discussion part where we explain more in depth how we envision that specificity in tissue-specific target gene regulation by Hox TFs is achieved.

Reviewer \#3:

> I have mixed responses to the paper by Domsch et al. On the one hand, the experimental design, to analyze Hox regulatory mechanisms in distinct embryonic tissues, seems at first glance important and exciting, I was less impressed with the analysis than I expected to be. My concerns fall in two categories:
>
> 1\) Data generation and analysis.
>
> For one, although replicates were analyzed for the RNA-seq experiments, it seems that all of the ChIP-seq datasets were only done once, without replicates. Given how noisy these type of data can be (especially when working with a small number of sorted cells and weak ChIP signals as in this case) I think it is imperative to compare at least two experimental replicates and use peak calling algorithms that require two independent datasets to assess statistical relevance. The Venn diagrams in Figure 2---figure supplement 1 for example suggest that there are \~14,000 (!) Ubx peaks in the mesoderm and that more than 7000 of these are mesoderm-specific. These numbers are quite striking but as it stands it is not possible to know how solid they are without replicate datasets and rigorous statistical tests.

We apologize if this was written in an unclear manner, but we had done all experiments of course at least in duplicates. To clarify: for the general mapping of tissue specific binding sites of Ubx we performed ChIP and HiSeq on two biological replicated. The experiments of the Ubx degradation (UbxDegrad) were performed in three biological replicates, the control (twi-INTACT; GFP-Ubx, UAS-Nslmb) as well as the experiment (twi-INTACT; *Mef2*\>UAS-Nslmb,GFP-Ubx). For the analysis of differential Expression (RNA-Seq, DESeq) and differential Binding (ChIP-seq, DiffBind) the two most similar replicates were identified and analyzed. For the identification of active genes or Ubx bound regions, we identified matching Ubx ChIP-seq replicates via person correlation, combined the data sets for further analysis and have (as requested by reviewer \#2) used a less stringent threshold of \>5 RPKM threshold for the tissue specific transcriptome data sets (dm6 *Drosophila* genome). This changed the number of genes to which Ubx binds. We obtain now 6417 Ubx bound genes at stages 10-13 and 8256 Ubx bound genes at stages 14-17 in the mesoderm, with 80% of them corresponding to coding genes and 20% to non-coding genes. Thus, in total Ubx binds to 37-46% of the genes in the *Drosophila* genome (total number of coding genes in the dm6 genome is 13971) using these settings. Although this number is now reduced, the overall take home message is the same: Ubx binds a lot of sites, Ubx controls lineage development comprehensively (see comments to reviewer \#2), and Ubx controls lineage development by repressing alternative fate genes and by activating lineage specific genes.

> I also wonder about the way the authors subtract input ChIP signals from their experimental IPs, as this is an analysis method that is not typically seen in the literature. I would like to see how noisy the input IPs are \-- those tracks should be shown.

As requested by the reviewer, we have added the input tracts to one sample (Figure 2---figure supplement 1A). We would however highlight that the subtraction of the Input from the IP is a common method to show the binding peaks and is used by many researcher groups, as it is normalizing the ChIP-seq reads (Erceg et al., 2017; Gaertner et al., 2012).

> There is little validation of the ChIP peaks. The only known enhancer that was highlighted was one from Dpp.

As requested by the reviewer, we now show another example in Figure 4---figure supplement 1A, the *βTub60D* enhancer, this gene is significantly down-regulated upon Ubx degradation.

> The Pho co-IP signal is surprisingly weak given the mechanism of co-recruitment that the authors are proposing.

We have performed whole embryonic Co-IP using the GFP-Ubx line, as a control we used the *w1118* fly line, and we found an interaction of Ubx with Pho in an in vivo context, which to our knowledge has so far not been shown for a Pho-TF interaction. And actually, we do not propose a direct recruitment or co-recruitment but we state that Ubx stabilizes Pho binding to repressed regions. The weak signal suggests that the interaction of Pho with Ubx is rather weak but essential for the maintenance of the repression. We have now stated this even clearer in the text.

> GAGA-like motifs are often observed by motif discovery algorithms and I am not convinced they are meaningful here given the lack of solid follow up evidence.

We assume a lot of genomic regions to contain the GAGA or GAGA-like motif and we agree that motif search does not that these regions are functional or bound by GAGA. However, we do think that some Ubx bound regions will have GAGA bound, as we could show an interaction between Ubx and GAGA at least in cell culture (Co-IP, now Figure 8---figure supplement 1D).

> One potential strength of the paper is the claim that Pho binding and K27me3 depends on Ubx binding. However, this conclusion is based on a small handful of loci analyzed by qPCR and the differences are small. Further, given that the Pc system can have very specific targets, I think that calculating the ratio of K27me3/K27ac can be misleading. Better to treat these marks independently, since when one is lower it isn\'t necessarily the case that the other will be higher. It is also the case that Pho binding is not equivalent to K27me3; the latter could simply be a consequence of whether the gene is repressed, which may or may not occur in a Pho-dependent manner.

We agree with the reviewer and we have redone the analysis using the Pho ChIP-seq dataset we have generated (in control and Ubx degradation backgrounds) to show the global relevance of our finding. In addition, we show K27me3 and K27ac marks independently. This analysis now reveals that a subset of Ubx-Pho bound sites that lose Pho binding in the absence of Ubx have their K27me3 marks significantly reduced, while K27ac marks are increased, demonstrating that at least at a subset of sites Ubx is required for Pho binding and H3K27me3 marks. We have now emphasized this point also stronger in the paper.

> Many genes lose expression in the Ubx knockdown experiments, suggesting that Ubx also acts as an activator in the mesoderm, but this is not adequately discussed or studied in the paper. It is not clear why the authors choose to focus on the repressed genes.

We agree with the reviewer that it has not been explained well enough why we chose to focus on repressed genes, which we have now done in the revised version. We have now dedicated also a paragraph in the Discussion on the activation of lineage-specific genes by Ubx to highlight that Ubx controls lineage development not only by repression.

> 2\) General comments.
>
> Ubx, and Hox genes in general, are well studied transcription factors that are known to be important in multiple cell types including mesoderm, the nervous system, and epithelium. So, seeing lots of genes change their expression when a broadly used transcription factor like Ubx is knocked down. It is also not surprising that the genes differ depending on the tissue (thus the GO analyses done in this paper seems rather trivial). What would take the analyses beyond what is known already is to understand how Ubx carries out differential functions in these two (and other) tissues. Presumably this happens in conjunction with tissue specific factors (e.g. twist for the mesoderm). The role of lineage specific factors, however, is not addressed and only marginally mentioned in the paper.

We would like to highlight that although it might seem trivial and expected to see a lot of genes changing their expression when Ubx is lost, this is the first time that a Hox TFs, which is active in many different cell types, is studied in individual lineages in vivo. Reviewer \#1 and \#2 appreciated this aspect a lot, as they thought this is an elegant study. It was in particular this set-up that allowed us to uncover the function of Ubx in repressing alternative fates. We do agree with the reviewer that the next interesting and important question to solve is how Ubx performs this function lineage-specifically, very likely via the interaction with lineage-specific factors. We work on that aspect, but this is beyond the scope of this paper, as this manuscript is already quite complex (stated by reviewer \#1).

> Terms such as \"Cell plasticity\" and \"lineage restriction\" are used rather loosely. The authors show that many up-regulated genes after Ubx knockdown are expressed in other lineages, but this result would have to be the case when a TF that represses genes is removed. There is no hard-evidence of lineage conversion (like loss of mesodermal master-regulatory factors for example), nor is it clear why neuronal (as opposed to endodermal or epithelial genes) genes are the focus here. It seems that the analysis is artificially restricted to repressed neuronal genes, while a more unbiased analysis of the changes that occur would be more valuable.

We went critically through the manuscript and used the terms "cell plasticity" and "lineage restriction" in a more stringent manner. Concerning the second point, that there is no hard evidence for lineage conversion, we would like to highlight that we never state that the mesodermal lineage changes identity in the absence of Ubx. Actually, we dedicated a whole paragraph in the Discussion why we believe that there is no lineage conversion, one reason being that other Hox TFs (like Antp) are ectopically expressed when Ubx is removed, which are very likely involved in maintaining the expression of mesodermal master-regulators. Thus, it will be important to study lineage development in a Hox free environment. However, this is beyond the scope of the paper. We now state more clearly why we focused on neuronal genes in our GO term analysis. However, we would like to highlight that we show the global significance of the de-repression of different types of alternative fate genes in Figure 3O.
